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Abstract
Mammographic screening is a method for detecting breast cancer at an early stage
of the disease progression, and is thus considered a secondary prevention. The
Norwegian Breast Cancer Screening Program invites all women aged 50-69 years
to mammographic screening biennially. The benefit of attending screening is eval-
uated by estimates of reduced breast cancer mortality among women invited and
women screened.
We introduce causal inference to estimate the benefit of attending screening. As
attendance to screening is optional, there is a possible selection bias when compar-
ing women who never attend with women who regularly attend screening. We
apply inverse probability weighting (IPW) to compensate for underlying differ-
ences between the comparison groups, under the assumption of no unmeasured
confounders. A Cox proportional hazard model estimate the risk of breast cancer
death to be 63% lower among the women regularly screened (HR=0.37, 95% CI:
0.32-0.43) compared to women never screened. The correction for selection bias by
IPW does not have an impact on the estimated effect of mammographic screening,
and we conclude that the covariates available do not introduce bias with respect
to breast cancer mortality. Further, we are interested in the magnitude of selection
bias. We consider an unknown factor representing any beneficial covariates asso-
ciated with a reduced mortality. This factor needs to be 7 times stronger in women
regularly screened compared to women never screened in order to eliminate the
estimated effect of mammographic screening on breast cancer mortality.
The aim of this thesis is to present a methodological framework in which we can
estimate the effect of mammographic screening on breast cancer mortality includ-
ing a possible effect of the women’s screening history. We describe one possible
way to achieve the true effect of screening and present the underlying assump-
tions. The assumption of no unmeasured confounders is violated in the currently
available data, and we are thus not be able to find the true effect of mammographic
screening on breast cancer mortality in this thesis.
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Chapter 1
Introduction
Breast cancer is the most common cancer in women worldwide, also in Norway [1].
In 2013, 3200 Norwegian women were diagnosed with a breast cancer [2]. Of to-
day, regularly mammography is the method used for detecting breast cancer at
an early stage and thus reduce the mortality from the disease. The Norwegian
Breast Cancer Screening Program (NBCSP) is a governmental, nationwide health
service which offers mammographic screening to all women aged 50-69 years. The
purpose of mammographic screening is to detect breast cancer at an early stage,
and reduce breast cancer mortality. The major harm is false positive screening re-
sults and overdiagnosis [3]. Overdiagnosis is defined as tumors that would not
have been diagnosed during a woman’s life time if she had not attended screen-
ing. There is an ongoing debate about the balance between benefits and harms of
organized mammographic screening [4, 5].
The ideal way to study the effect of mammographic screening is by randomiz-
ing the intervention in a randomized study. The NBCSP was implemented with-
out conducting such a study because several studies showing a reduced mortality
among those invited were already published. However, performing a randomized
study today is not ethical or possible almost 20 years after the introduction of or-
ganized mammographic screening. When doing a randomization we study the in-
tention to treat (effect among invited), and not the actual effect of screening (effect
among attendees). As mammographic screening is a well established routine, it is
likely that a large number of women would not follow their assigned, randomized
treatment, and there would be contamination in the randomized study. Hence, of
today, a randomized study of mammographic screening seems to be unobtainable.
Different methodological approaches of observational studies has been con-
ducted to estimate the reduction of breast cancer mortality as an effect of screen-
ing. In ecological studies, areas or regions are compared before and after imple-
mentation of screening, while incidence-based mortality studies follow screened
and non-screened women over time, from invitation to diagnosis and death. Each
of the different methods have advantages and limitations. The ecological studies
struggle to differentiate who is invited, and who attended, and can not specify if
the cancers are detected before or after the invitation to screening. The incidence-
based studies must deal with the underlying difference in the screened and non-
screened women. Several of these approaches have been used to estimate the effect
of the NBCSP on breast cancer mortality [6–9].
In addition to these structural differences in estimating the effect, we can also
arrange the invited women into comparison groups of screened and non-screened
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women in several different ways. Studies published of today on individual level
data have compared invited women who have attended screening at least once,
with invited women who have never attended screening. With this definition,
the estimated benefit is the effect of at least one attendance to screening on breast
cancer mortality. As the NBCSP invites women 10 times during a 20 years period,
women can attend at any of the received invitations and obtain any combination
of attendances and non-attendances. Thus, an alternative arrangement compare
women who attend screening regularly at every invitation and those who never
attend screening. Results using both definitions are interesting when analyzing the
effect of screening. The difference between women regularly screened and women
never screened is assumed to be larger than the difference between ever screened
and never screened women, because of less favorable tumor characteristics among
women with irregular attendances [10].
In general, mammographic screening will forward the time of diagnosis, and
extend the average time from diagnosis to death, even if the screening has no ben-
efit. Comparison of breast cancer mortality in women offered screening and in
women not offered screening, is thus an adequate way to estimate the benefit of
mammographic screening [3]. As screening is expected to prolong the time from
diagnosis to death, survival analysis of the women with a breast cancer diagnosis
must consider the difference in detection. The time the diagnosis is forwarded due
to screening is known as the lead time and introduces bias in survival analysis. By
using mortality as the outcome of interest, we can ignore the time of diagnosis and
by that avoid the issue of lead time. Another advantage of omitting the event of
breast cancer is the issue of overdiagnosis. Any overdiagnosed breast cancer will
not affect the mortality estimate because these cases can, by definition, not cause
breast cancer death.
Ideally we want to compare breast cancer mortalities in two identical popula-
tions where mammographic screening is implemented in only one of them. This
way of thinking is fundamental in causal inference, where we study the effect of
an intervention by comparing two representations of one population; one hypo-
thetical population where everyone receives the treatment and one hypothetical
population where no one receives the treatment. The effect of mammographic
screening will in this thesis be estimated by comparing women regularly screened
and women never screened. The main goal of this thesis is to describe a method-
ological framework in which we can estimate the causal effect of mammographic
screening on breast cancer mortality. We will discuss how this can be done us-
ing theory of causal inference on the data currently available. By presenting the
method and the underlying assumptions, we clarify the advantages and limita-
tions of this approach. The suggested framework is founded on a set of assump-
tions we are unable to fulfil with the data currently available. We can use the
described framework to estimate the effect of mammographic screening, although
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we might not be able to arrive at a conclusion in this thesis. However, with more
detailed data material in future research, the described methods can be used to
find the true effect of mammographic screening. We will not compare estimated
results with published literature in the field, as the focus is the methods used and
the assumptions made.
In the following chapter the organization of the NBCSP is described and the
available data material used in the thesis is presented. Chapter 3 introduces the
method used for modelling the attendance to screening and describes the proba-
bility of attending screening given history of previous attendances; chapter 4 de-
scribes the theory of causal inference and how this can be used to estimate the effect
of screening on breast cancer mortality. The method is applied under a set of as-
sumptions to the available data material in chapter 5. The underlying assumptions
are discussed briefly in chapter 6 and a conclusive discussion is given in chapter 7.
In appendix A we have included additional results and a description of the Stata
programming code written for this thesis is given in appendix B.
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Chapter 2
Mammographic screening
2.1 The Norwegian Breast Cancer Screening Program (NBCSP)
The Norwegian Breast Cancer Screening Program started as a pilot in four coun-
ties in 1996. After a gradual implementation, the program became nationwide in
2005 [11]. The Cancer Registry of Norway is responsible for the administration of
the program, planning the invitations, information about the program, the regis-
tration and quality assurance of the data and performance of the program. The
Health Trusts are responsible for running the program in the different counties. In
parallel with the implementation of the screening program, 16 breast clinics were
established in Norway. The program invites all women aged 50-69 years, residing
in Norway, to mammographic screening every two years. All women in the target
population listed in the National Registry receive an invitation. There is however
a small number of women (n<50) who have opted out of the screening program
before they would receive their first invitation, and by that reserved themselves
from receiving any invitations at all to the NBCSP. The women invited have the
possibility to opt out of the screening program at any time. Invited women receive
a personal letter with stated time and place for the examination. The screening
attendance is optional, and a reminder is sent to the women who do not respond
to the original invitation. This means that a woman can choose to attend or not
to attend, and regardless of her choice she will receive a new invitation two years
later. Women who are diagnosed with a breast cancer will not receive invitations
to screening after the time of the diagnosis as these women have individual follow-
up outside the screening program. The scheduling of the invitations is based on
the women’s birth cohort and place of residence. Due to the staggered implemen-
tation of the screening program and the two years screening interval, the invited
birth cohorts differ between counties and over time. Thus, the NBCSP schedule
women to be invited for the first time at the age of 48-52 years [12]. When the
screening program was implemented in each county, all women in the target pop-
ulation were invited within the first two years. In fact, the women were therefore
invited for the first time at all ages (48-73 years) in the start up of the screening pro-
gram. The average attendance rate for the program at each invitation is 75%, while
84% of the invited women have attended at least once. Two breast radiologists in-
dependently read the screening mammograms and classify with a score ranging
from normal findings to highly suspicious findings for breast cancer. Based on
this score the women are recalled for further assessment. All breast cancer diag-
noses, for women in all ages, are reported and stored at the Cancer Registry, and
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are linked with the data from the screening program.
2.2 Study population
Individual level data on women invited by the NBCSP include date of invitation
and attendance, county of residence and date of diagnosis of breast cancer. The
registry data are complete for all women in the target population, which means
that we will have no missing values or unregistered events for the key variables
of the administration of the program. In addition to the data from the Cancer
Registry, date of birth and date and cause of death are reported from Statistics
Norway and are linked to the screening data.
Figure 1: The birth cohort of women in-
vited to the screening program in a county
where the NBCSP was implemented in 1996.
The highlighted cells show an example of a
woman born in 1935, invited 5 times from
1996 to 2004, when she reaches the age limit
of the target population.
By the end of 2009, 2.5 millions
invitations had been sent to 720 000
women in the NBCSP. Women attend
at 75% of the received invitations, rang-
ing from 63% to 86% in the different
counties. Oslo is represented among
those with lowest attendance rates. As
women were invited at all ages within
the target population of the program
when the program was implemented,
the average and median age at first in-
vitation is 55 and 53 years. The av-
erage and mean time from one invita-
tion to the next is 738 and 731 days,
respectively. Mean and median num-
bers of screens in each woman were
3.5 and 4, respectively. Approximately
4% of the women in the target popu-
lation have opted out and will not re-
ceive invitations to the NBCSP. During
the last 10 years, 3% of the screening
examinations show abnormal findings,
and these women are recalled for fur-
ther examinations. For most of the re-
called women the findings are normal
or benign (80%), but some are diag-
nosed with a pre-malignant lesion or
an invasive breast cancer. Out of 1000
screening examinations, approximately 5 women are diagnosed with an invasive
breast cancer, and 1 woman is diagnosed with a non-invasive breast cancer, ductal
13
2 MAMMOGRAPHIC SCREENING
carsinoma in situ (DCIS) [11].
The study period for this thesis is defined as 1996-2009. We follow the women
from the time they receive their first invitation and to the end of 2009, emigration
or death, whichever came first. Figure 1 shows an example of the organization of
the screening program in a county where the start up was in 1996, over women’s
birth cohort in the study period. A woman who enters the screening program in
1996 at the age of 61, is expected to receive 5 invitations at two years intervals.
This woman’s age will exceed the upper age limit of the target population before
the end of 2009.
Table 1: The observed number of women, breast cancer cases and breast cancer deaths in the data
material, by predicted minimum number of invitations
Minimum
number
of predicted
invitations
Number of
women
observed
Breast
cancer
cases
Breast
cancer
deaths
1 699209 17415 1388
2 619423 16525 1305
3 521411 14989 1177
4 392760 12405 984
5 218936 8227 721
6 118673 5287 482
7 73851 3555 332
As we follow the women over time, the women at the oldest age groups exit the
target population and will stop receiving new invitations. Similarly, new women
will enter the target population when they reach the lower age limit for receiving
an invitation. Based on the age limits of the screening program and the defined
study period, we can predict the number of invitations that will be received from
the inclusion to the end of the study period (Table 1). In total there are 699 209
women who have received at least one invitation to the screening program. How-
ever, we want to follow the women who receive multiple invitations, and therefore
we include only those who are expected to receive at least three invitations within
the study period. Thus, our study population consists of 521 411 women invited to
screening. This means that we include women invited at least four years prior to
the end of 2009, and those who will remain in the target population of the screening
program at least four years after their first invitation. As an example we exclude
the women invited for the first time at the age of 66 and older, when the upper age
limit is 69 years. All women invited for the first time after 2005 are also excluded.
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The advantage of this inclusion criteria is that when all women are expected to
receive a minimum number of invitations, observed variations are not due to ad-
ministrative reasons. In the study population, there will be some women who
have received less than three, and more than three invitations. Even though the
screening interval is scheduled to be every two years, women may postpone their
screening examination or move to another county which will change the expected
screening interval. For women who have opted out of the screening program or
have a breast cancer diagnosis, the next scheduled invitation and future invitations
are cancelled.
The women included in the study were free from breast cancer at the time of
their first invitation. Hence, any observed breast cancer death has a breast cancer
diagnosis between the first invitation and the time of death.
In the study population of 521 411 invited women, 76% choose to attend and
24% choose not to attend the first invitation (Figure 2). In the time interval between
the first invitation and the next scheduled invitation, 3048 screened women have
a breast cancer diagnosis. Among the non-screened women, 857 have a breast
cancer diagnosis. Among the women invited once, 504 171 women (97%) receive
a second invitation. Among those who attended the first invitation, 89% choose
to attend and 10% choose not to attend their second invitation, and 1% do not
receive a new invitation. Among the non-attendees at the first invitation, 32%
choose to attend and 59% choose not to attend at the second invitation and 9% do
not receive a new invitation. At the second invitation 2535 screened women and
686 non-screened women have a breast cancer diagnosis. Similarly, we can observe
the attendance status among the women from the second to the third invitation.
87% of those screened at the second invitation continue attending screening at the
third invitation, and 62% of those not attending at the second invitation choose
to continue not being screened at the third invitation. 5% of the screened women
and 11% of the non-screened women do not receive a third invitation. Figure 2
illustrates that the women who attend screening are more likely to attend screening
at the next invitation. Similarly are those not attending most likely to continue
not attending screening. However, a larger part of the non-attendees switch to
attending compared to the number of attendees who stop attending. In the study
population, 91% of the women received at least three invitations to the screening
program within the study period.
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1st invitation 2nd invitation 3rd invitation
Number of invited:
521411 women
Number of invited:
504171 women
Number of invited:
473279 women
n=521411
n=398753 (76%)
n=122658 (24%)
n=393772 (78%)
n=110399 (22%)
n=371637 (78%)
n=101642 (22%)
Study
population
Screened
Non-screened
Screened
Non-screened
Screened
Non-screened
354053 (89%)
71581 (59%)
397
19
(32
%)
38818 (10%)
342157 (87%)
68669 (62%)
294
80
(27
%)
32973 (8%)
9% 11%
1% 5%
No new invi-
tation: 5882
(Cancer: 3048)
No new invi-
tation: 11358
(Cancer: 857)
No new invi-
tation: 18642
(Cancer: 2535)
No new invi-
tation: 12250
(Cancer: 686)
Figure 2: Float chart of the women in the study population invited to the screening program
2.3 Questionnaire
2.3 Questionnaire
All women invited to the NBCSP receive a questionnaire together with the invi-
tation letter, and the attendees are recommended to submit the questionnaire at
attendance [13]. The data from the questionnaires is available on aggregate level
and is only available for the attending women. The form includes questions about
the woman’s health conditions before age 50, and the woman’s current health and
lifestyle. In 2006, the questionnaire forms were changed from including catego-
rized alternative responses to report continuous responses for a number of the pa-
rameters. The included topics remained unchanged, but the data is more accurate.
The response rate for the questionnaire is 75% among the women attending. This
information will not be used in the main analysis in the thesis, but is presented to
show the possible source of information for future work. This information is how-
ever briefly described in chapter 6 to assess the differences between the screened
and the non-screened women. When using the data described, the two forms are
reformatted and merged such that the data can be analyzed from the start of the
screening program until the end of the study period.
2.4 Prognostic and predictive factors related to breast cancer and
breast cancer death
We want to compare the mortality in a group of women attending screening and a
group of women not attending screening. An observed difference in breast cancer
mortality between these two groups can be explained by two main factors; the
actual effect of screening and an underlying difference in risk of breast cancer death
for the two groups.
Screening is expected to detect breast cancer at an early stage such that prog-
nosis is improved by beneficial tumor characteristics and early treatment. The
women diagnosed with breast cancer as a result of attendance might have another
risk of breast cancer death compared with those who did not attend. Screening
can therefore have an impact on prognostic factors, objective characteristics of the
breast tumor, which often determine the course of treatment. Tumor characteristics
of the breast cancer are of great importance for predicting breast cancer death, but
will not be actively used when studying mortality in screened and non-screened
women.
Only women with a breast cancer diagnosis can die of the disease and we are
therefore interested in risk factors for breast cancer. Covariates such as age, family
history of breast cancer and previous benign breast lesions are proved to increase
the risk of breast cancer [14, 15]. Other possible confounders are age at menarche,
age at first birth and number of children. Lifestyle factors such as physical activity,
alcohol consumption, smoking habits, diet and body mass index have also been
17
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related to risk of breast cancer [14]. Hormonal therapy (HT) is used by women
at menopause and has been shown to increase the risk of breast cancer [16, 17].
However, in a study recently published, this association has been questioned [18].
Although this might be debated, we treat use of HT as a risk factor for breast cancer
in this thesis.
Some of these factors are predictive factors that provide information on the
likely benefit of the treatment. Factors of possible influence for breast cancer mor-
tality are general health conditions and lifestyle. Calendar year is an important
predictive factor for breast cancer death. Calendar year represents any change that
has happened over time. A large part of the observed change over time is due to
improved treatment including surgery, tamoxifen (anti-hormonal treatment), tar-
geted radiation and immune therapy, and this has resulted in a decrease in breast
cancer death over time [2, 14].
However, the fact that the screening examinations are optional introduce a
source of possible selection bias when comparing the women attending and not
attending screening. Some of the observed difference in breast cancer mortality is
likely to be caused by the underlying difference in the women choosing to attend
and the women choosing not to attend.
Attendance is likely to be influenced by social and demographic factors that
can be related to the risk of breast cancer death [19]. Differences over time can be
explained by changes of health awareness in the population, debates about benefits
and harms of mammographic screening and general coverage of topics like breast
cancer and screening in the media.
Selection bias related to attendance to screening and breast cancer mortality is
referred to as the healthy screening effect [3]. This term is used to describe the un-
measurable, individual factor that is present in women who attend screening. This
individual factor can be a combination of several variables, such as general health
conditions and lifestyle, socio-economic status, education, use of hormonal ther-
apy, and previous benign breast lesions in the woman herself or in the woman’s
family. For example, it is less likely that women with a poor general health will at-
tend screening, either due to difficulties doing a breast examination or due to other
issues. Such women are likely to have a higher risk of death compared to healthy
women, and will thus explain some of the difference between screened and non
screened women. The amount of unmeasured selection bias can be reduced if we
are able to control for factors associated with attendance to screening and the risk
of breast cancer death. If we adjust for all measurable and recorded factors we
can eliminate these from the definition of the healthy screening effect. Ideally we
adjust for all measurable confounders and we are left with unmeasurable factors
such as a subjective opinions, health awareness and social responsibility.
The attendance rates differ between counties and between age groups. Is it
possible that the magnitude of a healthy screening effect differ between counties?
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death
In a county with low attendance rate, we would expect the difference between the
screened and the non-screened women to be smaller, compared to a county with a
very high attendance. If it is so, the healthy screening effect is somehow related to
the overall attendance rates. This indicates that the healthy screening effect does
not apply equally to all groups within the study population [20].
We have discussed a long list of possible covariates needed for predicting atten-
dance to screening and breast cancer mortality. In this thesis we have information
about age and year of invitation in addition to county of residence. The rest of the
variables are unavailable, and we will not be able to fully predict the attendance
to screening in this thesis. Nevertheless, covariates like use of HT, family history
of breast cancer, social and demographic factors and lifestyle are of importance
when we want to compare breast cancer mortality in women regularly screened
and women never screened. In chapter 6 we will look at additional sources of
aggregated data to compare the distribution of possible confounders in women
screened and non-screened, to get an idea of which of the groups have the higher
underlying risk of breast cancer death. If we observe large differences in the distri-
bution of the confounders, one of the groups may have a higher underlying breast
cancer mortality. Thus, the estimated effect of mammographic screening is likely
to be biased. If the screened women have a lower underlying risk of breast cancer
death compared to the non-screened women, we expect the breast cancer mortal-
ity to be lower in this group, even if mammographic screening has no effect. In
chapter 6 we will also discuss how large this underlying difference needs to be in
order to eliminate the estimated effect of screening.
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Chapter 3
Attendance to screening
The reasons why some women choose to attend screening whereas other women
choose not to attend screening are difficult to fully understand. Studying covari-
ates that can predict attendance will be very useful when we want to study the
difference between screened and non-screened women. The aim of this chapter
is to model the probability of attending screening as a function of possible pre-
dictors. Notation is introduced for describing events like invitations, attendances
and breast cancer cases as functions of an individual time scale. We will build a
statistical model with this notation that can predict the individual probability of
attending screening at each invitation. We apply the method to available data and
predict the probability that a woman chooses to attend, given that we know a set
of covariates for the woman at the time of invitation. The study population is de-
scribed in section 2.2. Age and year of the invitation and the county of residence
are available variables that might be of importance. In addition, we are interested
in analyzing the effect of previous attendances and non-attendances. The observed
combination of attendances and non-attendances are called attendance patterns,
and will be used to study this effect. There are two possible outcomes for each
invitation and thus we have 2K unique attendance patterns for women receiving K
invitations. In this chapter we use the notation X indicating an attendance and an
O indicating a non-attendance. A code, consisting of a set of characters, is made
for each woman, where each character represents a new invitation. The first char-
acter represents the attendance status at the first invitation, the second character
represents the attendance status at the second invitation, and so on. A woman re-
ceiving three invitations, only attending the third one will therefore be given the
code OOX.
This chapter involve a detailed description of how to study attendance assum-
ing complete information available. In this thesis, standard statistical notation is
used, in which upper case letters denote a random variable and lower case letters
denote a particular realization of that random variable.
3.1 Notation
Assume that we have a study population of n women invited to screening up to
three times, j = 1, 2, 3. We define Ai j as an indicator of attendance for woman i at
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invitation number j,
Ai j =
{
0 if woman i does not attend invitation number j
1 if woman i attend invitation number j.
At each invitation, we observe a set of covariates for each woman. Let Zi j refer
to this vector, recorded for woman i at invitation number j. This vector can include
any known covariates that are expected to have an effect on attendance. In this
thesis we observe information about calendar year, age and county of residence
for each woman at each invitation, such that Zi j = {Zyeari j , Zagei j , Zcountyi j }.
The women in the study population are followed for breast cancer throughout
the study period. We denote Bi j as an indicator for a breast cancer diagnosis for
woman i detected in the time interval between invitation number j and scheduled
invitation number j + 1,
Bi j =

0 if woman i does not have a breast cancer diagnosed between
invitation number j and scheduled invitation number j + 1
1 if woman i has a breast cancer diagnosed between
invitation number j and scheduled invitation number j + 1.
Now that we have specified the main parameters, we can summarize the avail-
able information we have for each woman i at invitation number j,
pii j = (Ai j, Zi j, Bi j), j = 1, 2, 3.
Lastly, we defineHi j as the history of woman i, including all information avail-
able for this woman up to invitation number j. This includes (Ais, Zis, Bis) for
s = 1, ..., j. By using Hi j we are able to keep track of previous attendances and
non-attendances for each woman, which will be referred to as history of atten-
dance.
Based on the administrative rules of the screening program described in sec-
tion 2.1, we can express some known facts. Given that a woman has received
invitation number j, we know that she has not previously had a breast cancer di-
agnosis, Bis = 0 for all j ≥ 2, s < j. We define county of residence as the county
the woman is residing in at the time of inclusion in the study population, such that
it is constant over time, Zcountyi j = Z
county
i1 , for all j ≥ 2. Further, we assume that
we know Zi j given Hi1. Age and year of invitation are linear with time, and can
therefore be calculated given the value at the first invitation j = 1.
We would like to study each invitation separately for each women. We can
divide the observation of each woman into sections including each invitation. This
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can be proved by specifying the likelihood for woman i, given a set of known
covariates Zi j
L
f ull
i =Pr(Ai1, Bi1, Ai2, Bi2, Ai3, Bi3)
=Pr(Ai1, Bi1)
3
∏
j=2
Pr(Ai j, Bi j|Hi, j−1)
=Pr(Bi1|Ai1)Pr(Ai1)
3
∏
j=2
Pr(Bi j|Hi, j−1, Ai j)Pr(Ai j|Hi, j−1).
The likelihood function at invitation number j is now a product of the probabil-
ity of attending screening given the history, and the probability of having a breast
cancer diagnosis given attendance and the history. The full likelihood L f ulli can be
written as a product of LAi and L
B
i when assuming that the two factors depend on
different parameters.
We will now use this individual likelihood function to describe how we can
model the probability of attending screening for the total population. We assume
that the individuals in the study population are an independent and identically
distributed sample. Since we are interested in modelling the attendance, we can
separately maximize the partial likelihood function
LA =
n
∏
i=1
LAi =
n
∏
i=1
Pr(Ai1)
3
∏
j=2
Pr(Ai j|Hi, j−1).
Here, each invitation can be studied separately for each woman because this partial
likelihood function is of the same form as the partial likelihood function would be
in a situation with independent Ai j’s.
3.2 Logistic regression model
From the partial likelihood, we can now split the follow up of every woman into
pieces of invitations. The probability of attending screening at the first invitation
can be estimated separately from the probability of attending the second and third
invitation. A logistic regression model can estimate these probabilities given a set
of covariates Zi, j and the history Hi, j−1 for j > 1. The history Hi, j−1 includes in-
formation about previous invitations and attendances, and the covariates include
information about year and age at current invitation and county of residence. By
using a logistic regression model, the probability of attending screening is mod-
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elled by the logit function
Pr(Ai j = 1|Zi j) = e
β0+β1Zi j
1 + eβ0+β1Zi j
for j = 1
Pr(Ai j = 1|Hi, j−1, Zi j) = e
β0+β1Z∗i j
1 + eβ0+β1Z
∗
i j
for j > 1
where we let Z∗i j include both the vector of covariates Zi j and information about
previous attendance patterns. β1 consists of as many elements as the number of
covariates included in Zi j. By fitting the data to a logistic regression model we
can estimate the parameters β0 and β1 by the method of maximum likelihood es-
timation. This can be performed using a statistical software package. Based on the
estimates, we can calculate the conditional probability that woman i will choose
to attend screening given previous invitations and attendances, year and age at
invitation and county of residence.
3.3 Results
We will now fit a number of logistic regression models for estimating the proba-
bility of attending screening given attendance at previous invitations. When mod-
elling the effect of year and age at invitation on attendance, we will not restrict the
relationship to follow a specific curve, and thus the covariates are included in the
model as spline functions. For each invitation, we will fit a new logistic regres-
sion model with spline functions of age and year of invitation and the county of
residence as a categorical variable. The model for the first invitation includes all
women invited to screening. For invitation number two we fit two models; one for
those who attended at the previous invitation (X) and one for those who did not
(O). The models for the third invitation is run separately for those attended twice
(XX), those who only attended the first (XO), those who only attended the second
(OX) and those never attended (OO).
Previous attendances are of great importance when estimating the probability
of attending the current invitation (Figure 3). Each line in the plots represents the
mean estimated probability of attending screening, over age at invitation (top row)
and year of invitation (bottom row), at the first, second or third invitation, respec-
tively. The mean estimated probability of attending at first invitation is 76%. At
the second invitation, the mean estimated probability is 36% for those not attend-
ing, and 90% for those attending the first invitation. Similarly, the mean estimated
probability is 17%, 76%, 54% and 93% for attending the third invitation for the
women with history of attendance OO, OX, XO and XX, respectively. This coin-
cide with the attendance rates shown in the float chart presented in section 2.2
(Figure 2).
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Figure 3: Estimated probability of attending screening at invitation number 1, 2 and 3, by age and
year of invitation. A previous attendance is denoted X and a previous non-attendance is denoted
O.
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There are large variations between the counties (Table 2). At the first invitation,
Hedmark has the lowest (64%) and Rogaland has the highest (87%) mean probabil-
ity of attendance. At the second invitation, Oslo has the lowest mean probability of
attendance for both categories of attendance patterns (O:27% and X:85%). Troms
and Sogn og Fjordane have the highest probability among the women not attended
at the first invitation (47%) and attended at the first invitation (94%), respectively.
At the third invitations, Møre og Romsdal (13%), Oslo (67%), Oslo (45%) and Hed-
mark (88%) have the lowest mean probability of attendance for the previous at-
tendance patterns OO, OX, XO and XX, respectively. Similarly, Finnmark (25%),
Oppland (82%), Finnmark (65%) and Rogaland (95%) have the highest mean prob-
ability of attendance for the previous attendance patterns OO, OX, XO and XX,
respectively.
As described in section 2.4 there are many covariates that are likely to have an
impact on attendance to screening. Probability of attending screening is likely to
be influenced by social and demographic factors, as well as use of hormonal ther-
apy, health awareness and family history of breast cancer. One hypothesis is that
women using hormonal therapy have a higher probability of attending screening
since these women are likely to visit their general practitioner more often and be
reminded of their increased risk of breast cancer and the importance of mammo-
graphic screening. If we include these variables in the models, we could study
which factors that had the strongest impact on the attendance. Further, this would
be highly relevant when comparing women regularly screened with women never
screened, as possible confounders can describe underlying differences between the
two groups. Unfortunately, we do not have information about any of these possi-
ble confounders on an individual level, and so we are unable to predict probabil-
ities of attending screening as functions of these variables. In section 6.3, we will
look at data available from the NBCSP questionnaire to get an overview of the dis-
tribution of possible confounders for the women choosing to attend screening and
women choosing not to attend screening. This is to get an overview of which of
the groups that have the higher underlying risk of breast cancer and breast cancer
death.
To investigate further the effect of attendance at previous invitations on the at-
tendance at the current invitation, we run similar analyses on a sub-population
with women who were expected to receive at least four invitations. When study-
ing the effect of attendance at each of the previous invitations, the previous one is
most important for predicting an attendance. Further details from these analyses
are given in the Appendix section A.1.
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Table 2: Mean estimated probability of attendance over county of residence and history of atten-
dance
1st
invitation
2nd
invitation
3rd
invitation
History of
attendance O X OO OX XO XX
Akershus 0.75 0.35 0.89 0.18 0.73 0.53 0.92
Aust-Agder 0.81 0.36 0.90 0.17 0.75 0.55 0.94
Buskerud 0.75 0.43 0.89 0.22 0.81 0.60 0.93
Finnmark 0.81 0.41 0.85 0.25 0.74 0.65 0.91
Hedmark 0.64 0.37 0.90 0.18 0.78 0.46 0.88
Hordaland 0.84 0.40 0.93 0.16 0.75 0.60 0.95
Møre og Romsdal 0.72 0.30 0.90 0.13 0.80 0.47 0.92
Nordland 0.81 0.45 0.91 0.22 0.82 0.61 0.94
Nord-Trøndelag 0.84 0.42 0.92 0.18 0.80 0.62 0.95
Oppland 0.68 0.37 0.90 0.19 0.82 0.55 0.94
Oslo 0.65 0.27 0.85 0.13 0.67 0.45 0.89
Rogaland 0.87 0.34 0.94 0.16 0.76 0.53 0.95
Sogn og Fjordane 0.83 0.43 0.94 0.18 0.80 0.55 0.94
Sør-Trøndelag 0.77 0.40 0.89 0.21 0.78 0.59 0.92
Telemark 0.81 0.33 0.90 0.15 0.74 0.56 0.93
Troms 0.83 0.47 0.91 0.20 0.80 0.61 0.94
Vest-Agder 0.80 0.41 0.91 0.16 0.77 0.57 0.94
Vestfold 0.75 0.39 0.91 0.15 0.77 0.49 0.92
Østfold 0.72 0.31 0.89 0.17 0.76 0.50 0.93
Total 0.76 0.36 0.90 0.17 0.76 0.54 0.93
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Chapter 4
Causal inference
In applied statistics, we are often interested in the relationship between an event
and the underlying cause. Theory of causation is a method for investigating this
relationship and understanding the underlying mechanisms [21]. Assume that we
want to estimate the effect of an intervention on a specific parameter. For mea-
suring this effect we would like to know what would happen if the intervention
was performed, but also what would happen if no intervention was performed.
Would the same outcome be observed? The main criteria for a causal connection
are strength, consistency and specificity [22]. These aspects describes how effective
an intervention is, and under what circumstances it works.
Theory of causal inference can be used to investigate the effect of mammo-
graphic screening on breast cancer mortality. The aim of this chapter is to create
a basis for analyzing this screening effect, and to discuss potential challenges we
might face when applying causal thinking to screening data. In this chapter the
treatment is considered one attendance to screening and the outcome breast cancer
death is considered a dichotomous variable. This is to create a foundation where
the concepts of causal inference can be illustrated. In the next chapter we will rede-
fine the treatment and the outcome such that it can be applied to actual screening
data. The theory of causal inference is found in the forthcoming book of Hernan
and Robins [21].
We start by presenting the basic ideas of causal thinking in a randomized study.
These concepts can be applied in an observational study under a set of assump-
tions. Observational studies do not have the same properties as randomized stud-
ies, and thus we introduce some methods that can be used in observational studies
to mimic these properties.
4.1 Counterfactual outcomes
Consider an individual who receive a treatment A and where we observe an out-
come Y. We want to study how different levels of A affect Y. Specifically, we
assume that the individual may either receive an active treatment (A = 1) or not
receive this treatment (A = 0). We consider a dichotomous outcome Y, taking the
values 0 or 1. Let Ya=1 be the outcome that would have been observed for the
individual under the treatment a = 1, and Ya=0 be the outcome that would have
been observed under the treatment a = 0. We say that the treatment A has a causal
effect on the individual’s outcome Y if Ya=1 6= Ya=0. This means that we would ob-
serve another outcome Y, had the individual received treatment A = 1 compared
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to treatment A = 0. The random variables Ya=0 and Ya=1 are referred to as counter-
factual outcomes. Each individual will receive only one treatment a, and experience
the corresponding outcome Ya. The outcome corresponding to the other treatment
will thus not be observed for this individual. An individual with observed treat-
ment A = a, has the observed outcome Y which is equal to the counterfactual
outcome Ya. This equality, Y = YA, is called consistency, meaning that we observe
the counterfactual Ya corresponding to the individual’s observed treatment A = a.
For this property to hold, we must assume that the individuals actually follow the
assigned treatment.
The individual causal effects are generally not identifiable because we will only
observe one of the counterfactual outcomes for each individual. Hence, we are
more interested in total populations in order to identify the average causal effect in
a population of individuals. Then the counterfactual outcome Ya=1 is the outcome
for a randomly selected individual in the population, had everyone received the
treatment a = 1. We define Pr{Ya=1 = 1} as the probability of the event in the pop-
ulation, if all individuals were treated with a = 1. Further, we define Pr{Ya=0 = 1}
as the probability of the event in the population, if all individuals were untreated
(a = 0). An average causal effect of treatment A on the outcome Y is present if
Pr{Ya=1 = 1} 6= Pr{Ya=0 = 1}.
Let us apply this concept to an example from mammographic screening. We
define screening attendance at one invitation as the treatment A, where A = 0 cor-
responds to not attend screening and A = 1 corresponds to attend screening. Fur-
ther we define the outcome Y as the dichotomous indicator of breast cancer death
within a 10 years follow up after this invitation. The probability of breast cancer
death that would have been observed in the population had everyone attended the
screening can be written like Pr{Ya=1 = 1}, and Pr{Ya=0 = 1} is the probability
of breast cancer death that would have been observed in the population if no one
attended screening.
For simplicity, we will use the term causal effect as the average causal effect
in a population. In this thesis we will represent the causal effects by the effect
measure causal risk ratio
Pr(Ya=1 = 1)
Pr(Ya=0 = 1)
, where we compare the risk of an event in
the population if all individuals received treatment (A = 1) and the risk of an
event in the population if no individuals received treatment (A = 0). Further,
we define the associational risk ratio as the risk in the sub-population of treated
individuals divided by the risk in the sub-population of untreated individuals,
Pr(Y = 1|A = 1)
Pr(Y = 1|A = 0) .
In an ideal situation we want to observe all counterfactual outcomes for all indi-
viduals in the population. This is impossible with real data where we only observe
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the actual outcome for each individual. Under certain assumptions, a randomized
study can be conducted such that an estimate of the causal effect can be achieved.
4.2 Randomized studies
Assume now that we can perform a randomized study such that every individ-
ual in a population is randomly assigned to one of two groups. One of the
two groups will receive the active treatment (A = 1), and the other will not re-
ceive this treatment (A = 0). Even though the counterfactual outcomes are not
observed, all covariates of the outcome will be equally distributed between the
treated (A = 1) and the untreated (A = 0) groups. This means that we ex-
pect the proportion of events among the treated to be the same whether indi-
viduals in the first group or the second group received the treatment. This is
known as exchangeability and is a key concept in randomization. Exchangeabil-
ity can be written as Pr{Ya = 1|A = 1} = Pr{Ya = 1|A = 0}. A randomized
study design has two fundamental concepts, consistency, Y = YA, and exchange-
ability. With these essential properties we can rewrite the counterfactual risk as
Pr{YA=a = 1} = Pr{Y = 1|A = a}. This means that we can compute the counter-
factual risk under treatment Pr{Ya=1 = 1} through computation of the risk in the
treated group Pr{Y = 1|A = 1}. Thus, this gives randomized studies a possibility
to calculate the true treatment effect because the causal risk ratio can be written as
the associational risk ratio
Pr(Ya=1 = 1)
Pr(Ya=0 = 1)
=
Pr(Y = 1|A = 1)
Pr(Y = 1|A = 0) .
When randomly assigning treatment to a population, the proportion of individ-
uals assigned to active treatment can be set to any value. If the number of indi-
viduals receiving active treatment is half the number of the comparison group,
treatment is assigned with a randomization probability of 33%. An unconditional
(marginal) randomized study using one common randomization probability, as-
signs all individuals to a treatment group completely by random. However, there
is a possibility of using different randomization probabilities for different subsets
of the population, based on levels of a variable L. Such a study design is called a
conditional randomized study and randomization is done within strata of L.
A conditional randomized study is a combination of multiple separate uncon-
ditional randomized studies, one conducted among individuals for each level of
L. The marginal exchangeability property of unconditional randomized study
does not hold. However, conditional exchangeability can be guaranteed, where
Pr{Ya = 1|A = 1, L = l} = Pr{Ya = 1|A = 0, L = l}. Similarly as for an
unconditional study, the key concept of consistency and exchangeability leads to
the property Pr{YA=a = 1|L = l} = Pr{Y = 1|A = a, L = l} for a conditional
randomized study.
In unconditional randomized studies we know that the casual risk ratio is equal
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to the associational risk ratio due to unconditional exchangeability. However, this
is not the case in a conditional randomized study, and
Pr(Y = 1|A = 1)
Pr(Y = 1|A = 0) is no
longer an effect measure for the causal effect of treatment A. Nevertheless, we
are able to find the causal effect measure by recalling that a conditional random-
ized study is a combination of two or more unconditional randomized studies,
conducted within subsets of the population. The first step is to calculate the causal
effect in each stratum of the population, for values of L, as in the unconditional
setting. The stratum-specific causal effects may differ in each stratum, and hence
there is an effect modification by L. In general, we are mainly interested in the causal
effect in the entire population regardless of L. Thus, the method of standardization
or inverse probability weighting is needed to combine the stratum-specific causal
effects.
Before we introduce these methods, we will add use of hormonal therapy L as a
dichotomous confounder to the mammographic screening example introduced in
the previous section. Hormonal therapy is known to be a factor that increases the
risk of breast cancer, and the distribution of users is likely to be different among
the screened and the non-screened women. Assume that we have a conditional
randomized study where we assign 75% of the women using hormonal therapy
(L = 1) to attend screening (A = 1), and 50% of the women not using hormonal
therapy (L = 0) to attend screening (A = 1). We record cases of breast cancer death
after a 10 years follow up (Y). Figure 4 is an illustration of how a population could
hypothetically be distributed after randomization. We may consider the percent-
ages in this example as probabilities of being assigned to a particular subgroup.
The distribution of Y in each of the four branches in the figure is an indicator for
the probability of breast cancer death in the subgroups categorized by screening
attendance A and use of hormonal therapy L. The breast cancer mortality in this
hypothetical population is much higher than in the general population, and it is
important to emphasize that the numbers in this example are for illustration pur-
poses only.
In the hypothetical population, we observe 60 women using hormonal therapy
(L = 1) and 40 women not using hormonal therapy (L = 0). Among the users,
75% are assigned to attend screening, Pr(A = 1|L = 1) = 0.75, whereas 25%
are assigned to not attend screening Pr(A = 0|L = 1) = 0.25. The 40 women not
using hormonal therapy are equally assigned to attend and not to attend screening,
Pr(A = 1|L = 0) = Pr(A = 0|L = 0) = 0.5. If we ignore the information on use
of hormonal therapy, we observe 9 + 4 = 13 breast cancer deaths among the 65
women attending, and 6 + 4 = 10 breast cancer deaths among the 35 women not
attending. At first sight, this indicates a probability of breast cancer death within a
10 years period of 20% and 29% among the screened women and the non-screened
women, respectively.
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Figure 4: A hypothetical population of 100 women invited to screening where use of hormonal
therapy (L), attendance to screening (A) and breast cancer death (Y) are recorded
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The information on the confounder L may be of great importance when es-
timating the effect of screening, and thus we estimate the stratum-specific risks
for values of L. The screened women who use hormonal therapy have a prob-
ability of Pr(Y = 1|L = 1, A = 1) = 9/45 = 0.2 of dying of breast cancer
within a 10 years period. Comparing this to those women who do not attend
Pr(Y = 1|L = 1, A = 0) = 6/15 = 0.4, showing a higher probability for breast
cancer death. The other branches of the tree in Figure 4 can be interpreted simi-
larly. The stratum-specific risks for breast cancer death within a 10 years period in
this hypothetical population is
Pr(Y = 1|A = 1, L = 0)
Pr(Y = 1|A = 0, L = 0) =
0.2
0.2
= 1
Pr(Y = 1|A = 1, L = 1)
Pr(Y = 1|A = 0, L = 1) =
0.2
0.4
= 0.5
There is a clear difference in risk ratio of breast cancer death within a 10 years
period for the two strata. Women not using HT have equal risk of breast cancer
death, but for women using HT the risk is twice as high among the women not
attending screening. We will use this example to illustrate how to combine the
risk ratios within levels of L, such that we can estimate the total causal effect of
screening on breast cancer death within a 10 years period.
4.3 Standardization
Standardization is a method used to find the total counterfactual risk by combining
each of the stratum-specific risks. This is done by weighting the stratum-specific
risks Pr(Ya = 1|L = l) for each value of L such that we attain the marginal coun-
terfactual risk Pr(Ya = 1). The weights are equal to the proportion of individuals
in the population with L = l, and the marginal counterfactual risk can be written
as
Pr(Ya = 1) = Pr(Ya = 1|L = 0)Pr(L = 0) + Pr(Ya = 1|L = 1)Pr(L = 1)
=∑
l
Pr(Ya = 1|L = l)Pr(L = l)
=∑
l
Pr(Y = 1|A = a, L = l)Pr(L = l). (1)
The last equality is correct because association is causation within each subset in a
conditional randomized study when using standardization.
Consider the hypothetical population of 100 women invited to screening (Fig-
ure 4). Standardization can be used to achieve the counterfactual risk if everybody
had attended screening and analogously if nobody had attended screening. By
32
4.4 Inverse probability weighting
using formula (1) for calculating the counterfactual risk we find that
Pr(Ya=1 = 1) =Pr(Y = 1|A = 1, L = 0)Pr(L = 0)
+Pr(Y = 1|A = 1, L = 1)Pr(L = 1)
=0.20 · 0.40 + 0.20 · 0.60 = 0.20,
and
Pr(Ya=0 = 1) =Pr(Y = 1|A = 0, L = 0)Pr(L = 0)
+Pr(Y = 1|A = 0, L = 1)Pr(L = 1)
=0.20 · 0.40 + 0.40 · 0.60 = 0.32.
Thus, the probability of breast cancer death within a 10 years period is 20% in the
hypothetical population if everybody attend screening. Similarly, the risk is 32%
if nobody in the population attend screening. With these results, we can compute
the causal risk ratio as
Pr(Ya=1 = 1)
Pr(Ya=0 = 1)
=
0.20
0.32
= 0.625.
In this hypothetical example, not attending screening is associated with a 60%
(1/0.625 = 1.6) higher risk of breast cancer death compared to the women at-
tending. By comparison, we found the risk of breast cancer death to be twice as
high for non-screened women among those using HT, and no difference among
those not using HT, when we calculated the associational risk ratios in each level
of L separately. It is intuitive that the combined risk is somewhere between the
stratum-specific risks.
4.4 Inverse probability weighting
The second method for combining stratum-specific causal effects are called inverse
probability weighting (IPW) and is an alternative method to standardization. Sim-
ilarly as with standardization, the goal is to identify the causal effect in the en-
tire population regardless of confounders L. The idea of IPW is to model both
counterfactual outcomes as if every individual had appeared both as treated and
untreated. Such a modified population is referred to as a pseudo-population and
include multiple copies of each individual in the original study population. The
pseudo-population is corrected for confounding factors and so the associational
risk ratio in the pseudo-population is equal to the causal risk ratio in both the
pseudo-population and the original population. We create this pseudo-population
by weighting the individuals in the original population with the inverse of the
33
4 CAUSAL INFERENCE
probability of receiving the actual treatment received, given all confounders. A
treated individual with L = l is given the weight WA = 1/Pr(A = 1|L = l).
We implement IPW to the screening example illustrated in Figure 4. 20 out
of 40 women with no use of hormonal therapy (L = 0) are screened, and so the
probability of attending screening in this subgroup is Pr(A = 1|L = 0) = 20/40 =
0.50. We observe 4 breast cancer deaths in this subgroup, and these are weighted
with 1/0.50 = 2. In the case where all non-users of HT are screened, 4 · 2 = 8
breast cancer deaths will appear among the 40 women with no use of hormonal
therapy. Among the women using hormonal therapy (L = 1), 45 out of 60 where
screened (A = 1). The probability of attending screening for this subgroup is
Pr(A = 1|L = 1) = 45/60 = 0.75. Thus, the 9 breast cancer deaths observed
in this subgroup are weighted with 1/0.75 = 1.33. If all women using hormonal
therapy attend screening, 9 · 1.33 = 12 breast cancer deaths will appear among the
60 women. We can summarize the computed weights as
WA=0L=0 = 1/Pr(A = 0|L = 0) =
40
20
= 2,
WA=0L=1 = 1/Pr(A = 0|L = 1) =
60
15
= 4,
WA=1L=0 = 1/Pr(A = 1|L = 0) =
40
20
= 2,
WA=1L=1 = 1/Pr(A = 1|L = 1) =
60
45
=
4
3
.
Combining these results we find that if the total population of 100 women attended
screening, then 8 + 12 = 20 women would die of breast cancer, Pr(Ya=1 = 1) =
20/100 = 0.20. Analogous, if no one in the hypothetical population attended
screening, there would be 4 · 2 = 8 and 6 · 4 = 24 breast cancer deaths in the
subgroup L = 0 and L = 1, respectively. Hence, if the total population of 100
women did not attend screening, then 8 + 24 = 32 would have died of breast
cancer within a 10 years period, Pr(Ya=0 = 1) = 32/100 = 0.32.
Using inverse probability weights to estimate the causal risk ratio, we find
Pr(Ya=1 = 1)
Pr(Ya=0 = 1)
=
0.20
0.32
= 0.625.
This is the same as we got using standardization, and that is no coincidence. The
individual weights WA = 1/Pr(A = 1|L = l) vary for individuals within values
of L. The general inverse probability weighted risk for treatment A = a can be
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written as
E
{
I(A = a)WAY
}
= E
{
I(A = a)Y
Pr(A|L)
}
=∑
y
∑
a,l
I(A = a)y
Pr(A = a|L = l)Pr(Y = y, A = a, L = l)
=∑
y
∑
l
y
Pr(A = a|L = l)Pr(Y = y|A = a, L = l)Pr(A = a, L = l)
=∑
l
Pr(Y = 1|A = a, L = l)Pr(A = a|L = l)Pr(L = l)
Pr(A = a|L = l)
=∑
l
Pr(Y = 1|A = a, L = l)Pr(L = l), (2)
where I(A = a) is an indicator taking the value 1 if A = a and 0 otherwise. Hence,
we have shown that for discrete variables A, L and a binary outcome Y, the meth-
ods of standardization (1) and inverse probability weighting (2) are equal.
4.5 Stable inverse probability weighting
We have now described how to correct for selection bias due to confounding fac-
tors L. Under a set of assumptions, this can be done by inverse probability weight-
ing. The weights WA create a pseudo-population where there is no association
between L and A. All pseudo-individuals are included both in the treated group
and the untreated group. Hence, the size of a pseudo-population is twice as large
as the original population, and the expected mean of the weights is equal to 2.
The weights will have the same properties of correction for bias when multiplied
with a factor p, WA = p/Pr(A = a|L = l), where 0 < p ≤ 1. As long as the
probability of treatment A does not depend on the confounders L, we can assign
the individuals in the pseudo-population to treatment with different probabili-
ties. We define p as the probability of receiving treatment A = a, and introduce
SWA =
Pr(A = a)
Pr(A = a|L = l) as the stabilized weights correcting for confounders L. The
numerator acts as a stabilizer to the weights and the denominator is equal to the
denominator of WA. The mean of the stabilized weights is expected to be equal
to 1 and the size of the pseudo-population will be equal to the size of the original
population.
4.6 Observational studies
Assume a randomized study is not possible to do, and that we are obliged to use
a different approach. An observational study differs from a randomized study
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in how the treatment is assigned to each individual. In observational studies we
observe which treatment the individuals attain without interfering and random-
izing. The main difference from a marginal randomized study is that in observa-
tional studies there are possible confounding factors that can have an impact on
the effect measurement. These variables are thus important to measure.
Assume we have a population where we offer active treatment (A = 1) to
all individuals. We observe which individuals who follow the active treatment
(A = 1) and who do not follow this treatment (A = 0). Similarly as in the ran-
domized study, we can not observe the counterfactual outcomes. An advantage of
a randomized study is that we randomize the individuals, either unconditional or
within strata of a variable L. However, in observational studies we can not influ-
ence the distribution of L in the treated and untreated groups and thus, there may
be large differences among the individuals receiving active treatment, and the in-
dividuals not receiving this treatment. In fact, the reasons for receiving treatment
are likely to be associated with some outcome predictors because the individuals
themselves choose which treatment to follow.
Randomized studies are able to identify causal effects because of exchangeabil-
ity. The strata within L in observational studies are not automatically exchangeable
since there is no randomized assignment to treatment, and this makes it more diffi-
cult to obtain a causal effect. However, there is one way an observational study can
achieve estimation of the causal effect, and that is under the assumption of the iden-
tifiability conditions. When the conditions are satisfied the observational study have
the same properties as a conditional randomized study, including conditional ex-
changeability where Pr(Ya = 1|L = l) = Pr(Y = 1|A = a, L = l). The identifiabil-
ity conditions have three criteria. First, the treatment must be well-defined, second
no unmeasured confounders and third, the probability of receiving the treatment
must be greater than zero for all individuals. When these conditions are met we
have conditional exchangeability, and thus we are able to calculate causal effects.
In the screening setting, attendance to screening is a well defined intervention
and all women are able to choose both treatments, and hence, the first and third
criteria of the identifiability conditions are true. The condition of no unmeasured
confounders is more challenging to satisfy. The possibility to use an observational
study design to estimate the causal effect of screening rely on the assumption that
we can identify and record all possible confounders for screening attendance and
breast cancer death. It is likely that we will never be able to measure all con-
founders. The best possible approach is to identify and measure the strongest and
most important confounders.
Consider the screening example including the dichotomous variable L indicat-
ing a use of hormonal therapy. We use an observational study design and observe
which women choose to attend screening (A = 1) and which women do not attend
screening (A = 0). We know that all women adhere to the chosen treatment group
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and different from the randomized study, no assumption on this is needed. Since
the attendees themselves take the decision on which group they will follow, there
might be large differences between the two groups. This will violate the exchange-
ability condition if we can not measure and control for all possible confounders.
In an ideal observational study, we would have no unmeasured confounders that
affect both the probability of attending screening and the breast cancer mortal-
ity. Hormonal therapy is such a possible confounder that is likely to be associated
with attendance and breast cancer death. Assume for illustration that use of hor-
monal therapy is the only confounder, and that we have information about use
for all women. If this assumption holds we have no unmeasured confounders
and the treated and untreated groups are conditionally exchangeable. First, we
have that Pr(Ya = 1|A = 1, L = l) = Pr(Ya = 1|A = 0, L = l). When the
identifiability conditions hold, the observational study can be conceptualized as a
conditionally randomized study. This means that we can use the methods of stan-
dardization or IPW to obtain the estimated causal effect of treatment in the entire
population, by combining stratum-specific causal effects for levels of L, such that
Pr(YA=a = 1|L = l) = Pr(Y = 1|A = a, L = l). In this situation, an observational
study will estimate the true causal effect of the treatment.
It is possible to include multiple covariates in the observational study by defin-
ing L to be a vector of k covariates, where L = (L1, L2, ..., Lk). The same proper-
ties still hold under the assumption of the identifiability conditions. Theoretically,
we can include all confounders that affect screening attendance and breast cancer
mortality, and thereby be able to estimate the true causal effect in an observational
study.
4.7 Loss of follow up
As we follow women for breast cancer death within a 10 years period, it is pos-
sible that we will not be able to follow all women throughout this period. When
we study death of a specific disease, loss of follow up can occur for individuals
who die of other causes or emigrate before experiencing the event of interest. Loss
of follow up can also happen when individuals choose to exit the study. When
we are no longer able to follow an individual, we will have a missing observation
and we say that the individual is censored (C = 1). Missing data due to loss of
follow up prevent us from recording the event of interest, and introduce selection
bias in our data. This is true if a covariate increase the risk of being censored and
also has an effect on the outcome of interest. We can not observe the outcome of
interest if the individual is censored before the event has occurred. In fact, what
we are interested in is estimating the effect of a treatment in a population where
everybody remains uncensored (C = 0). We now introduce Pr(YA=a,C=0 = 1)
as the probability of the event if everybody in the population had been treated
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with A = a, and everybody remained uncensored. This can be viewed as the true
causal effect of the joint intervention of A and C. When including C as a second
parameter to the causal statement, we will need to ensure that the exchangeability
and identifiability conditions also hold for C. The assumption of well-defined in-
terventions require a clear definition of censoring. Since we are only interested in
studying the effect of screening on breast cancer death, we categorize every loss of
follow up as a censoring. Hence, we have well-defined interventions. Under the
assumption of conditional exchangeability we assume that the groups of censored
and uncensored individuals have the same average outcome given equal values
of A and L. This means that there must be no confounding factors that affect the
selection Pr(C = 0|A = a, L = l) that are not taken care of by L. Unfortunately, we
can never know if all confounders are identified and recorded in L, which means
that the assumption is untestable. For now, we will also assume that we have con-
ditional exchangeability between the censored and uncensored subgroups in the
screening example. The property of positivity holds if all individuals have a possi-
bility to remain uncensored given A and L. In the screening setting, we claim that
positivity hold because all women have an initial possibility to remain in the study
throughout the study period.
Under the assumption that these conditions hold, we can, similarly as for A,
use IPW or standardization to compute the true causal effect of treatment. Let WC
denote the weight for a selected individual (C = 0) with the covariates L and A,
and define it as the inverse probability of being selected, Pr(C = 0|L = l, A = a).
For simplicity, we apply the non-stable weights, but the stable weights for C can
easily be computed by SWC =
Pr(C = 0|A = a)
Pr(C = 0|A = a, L = l) and used in the calcula-
tions.
The screening example illustrated in Figure 4 describe a situation where no one
was lost to follow up. The inclusion of censoring in the screening example is de-
picted in Figure 5. In the real world, we would never know how many breast can-
cer deaths occurred among the censored women. However, we will assume that
these numbers are known, and we will use the example to illustrate how to correct
for censoring. Of the 100 women, the distribution of attendance to screening and
use of hormonal therapy remains the same as before. Among the 15 women using
hormonal therapy and not attending screening, 7 where censored and 8 remained
uncensored. That is, the conditional probability of remaining uncensored in this
group is Pr(C = 0|L = 1, A = 0) = 8/15 = 0.53. The 8 uncensored women receive
a weight of 15/8. Inverse probability weighting replaces the 15 original women by
15/8 copies of each of the 8 uncensored women. The 7 censored women will not
contribute to the analysis, and receive a zero weight. When following this proce-
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dure for all subgroups, we end up with these weights:
WC=0L=0,A=0 = 1/Pr(C = 0|L = 0, A = 0) = 20/5,
WC=0L=0,A=1 = 1/Pr(C = 0|L = 0, A = 1) = 20/19,
WC=0L=1,A=0 = 1/Pr(C = 0|L = 1, A = 0) = 15/8,
WC=0L=1,A=1 = 1/Pr(C = 0|L = 1, A = 1) = 45/35.
These weights can be used to create a pseudo-population of women where
no one is lost to follow up. However, the pseudo-population created from these
weights will only adjust for bias due to loss of follow up. In the original example
described in Figure 4 we computed a separate set of inverse probability weights
WA, correcting for confounders L. To correct for both sources of bias simultane-
ously, we can combine these weights, WA and WC and define one common weight
WA,C =
1
Pr(A = a, C = c|L = l) . Using these weights, we can obtain the causal
effect under the assumption of exchangeability for the joint treatment (A, C) con-
ditional on L.
In the hypothetical population of Figure 5 we can derive WA,C by calculating
the probability for A = a and C = c with condition on L,
WA=0,C=0L=0 = 1/Pr(A = 0, C = 0|L = 0) = 40/5
WA=1,C=0L=0 = 1/Pr(A = 1, C = 0|L = 0) = 40/19
WA=0,C=0L=1 = 1/Pr(A = 0, C = 0|L = 1) = 60/8
WA=1,C=0L=1 = 1/Pr(A = 1, C = 0|L = 1) = 60/35.
It can be shown that the common weight WA,C is the product of the weights WA
and WC,
WA,C =
1
Pr(C = c, A = a|L = l) =
1
Pr(C = c|A = a, L = l)Pr(A = a|L = l)
=
1
Pr(A = a|L = l) ·
1
Pr(C = c|A = a, L = l) = W
A ·WC
We will now use the combined weights WA,C to create the pseudo-population
with adjustment for confounding L and censoring C. The exact estimates of the
number of breast cancer deaths are obtained by using the weights as fractions in
the calculation, but in this example we will round off to the nearest integer. Among
the women attending screening and using hormonal therapy, we observe 6 deaths
among the uncensored. In the pseudo-population, there would be 6 · 60/35 ≈ 10
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Figure 5: A hypothetical population of 100 women invited to screening where use of hormonal
therapy (L), attendance to screening (A), censoring (C) and breast cancer death for censored and
uncensored women (Y) are recorded.
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breast cancer deaths in this subgroup. Similarly, there would be 4 · 60/8 ≈ 30
breast cancer deaths among the women not attending screening and using hor-
monal therapy. The 3 breast cancer deaths among the women attending and not
using HT are weighted 40/19 and will result in 6 breast cancer deaths in the
pseudo-population. A large number of women are censored among those not us-
ing HT and not attending screening. The uncensored women in this subgroup are
weighted by 8 such that the one breast cancer death observed will count 8 in the
pseudo-population. Under the identifiability conditions, we can obtain the causal
risk ratio
Pr(Ya=1,c=0 = 1)
Pr(Ya=0,c=0 = 1)
by calculating the associational risk ratio in the pseudo-
population. We assume conditional exchangeability for A and C conditioned on L
and estimate the causal risk ratio by the associational risk ratio
Pr(Y = 1|A = 1, L = l, C = 0)
Pr(Y = 1|A = 0, L = l, C = 0) =
{(3 · 40/19) + (6 · 60/35)} /100
{(1 · 40/5) + (4 · 60/8)} /100
=
(6 + 10)/100
(8 + 30)/100
= 0.42.
The women not attending screening in this example have a 58% (1-0.42) higher
risk of breast cancer death within a 10 years period, when correcting for both cen-
soring and confounding by use of hormonal therapy. In this hypothetical popula-
tion, women not attending are more likely to be censored, and so this difference is
important to take into consideration when comparing the attendees and the non-
attendees. It is plausible that women with poor health conditions are less likely to
attend screening, and that they also have a higher risk of being censored.
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Chapter 5
Application to screening data
The aim of this chapter is to apply causal inference and estimate the effect of screen-
ing on breast cancer mortality. In the previous chapter we introduced the topics of
causality by using simplified examples from the screening setting. In the previous
chapter we described how causality can be applied to real data, and if that was the
goal we could stick to a simplified situation. However, in this chapter we elaborate
more details on the screening complexity to accommodate the described method
of causal inference for screening data.
We will redefine the definition of both treatment and outcome, to adapt to the
realization of the screening data. As described in the introduction, the goal is to
compare breast cancer mortality between women regularly attending and women
never attending. As women can receive multiple invitations, the treatment is now
defined as regular attendances (A∗ = 1) versus no attendances (A∗ = 0). We use
the term screened women for those attending screening regularly, and the term
non-screened women as those never attending. The outcome breast cancer death
is changed from being a dichotomous variable to be considered a lifetime variable,
starting at the inclusion in the study and continuing throughout the study period.
The previous chapter describes how to estimate the causal effect from an obser-
vation study under the identifiability conditions. In real data, these assumptions
are difficult to achieve. We will shortly describe factors that would be needed in
order to reduce the extent of unmeasured confounders. Then, we will introduce
notation such that we can use lifetime modelling to fit the data with available co-
variates. Further, we will propose a set of inverse probability weights to correct
for possible bias. At the end of this chapter we will present a structural model and
estimate the effect of screening on breast cancer mortality by fitting the structural
model to the pseudo-population created.
5.1 Confounders
As previously mentioned, we will never be able to claim no unmeasured con-
founders for attendance to screening and breast cancer death. Even if we believe
that we have all measurable covariates we can never know if some unknown un-
measurable covariate introduce bias. In section 2.4 we presented a set of risk fac-
tors associated with attendance to screening and breast cancer death. Most of these
covariates are unavailable in the current data material, and we will therefore only
be able to adjust for a few variables. Data from the Cancer Registry include age and
year of invitation and county of residence on an individual level, for all women in
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the study population. We will use age at invitation as a predictor V and year of
invitation and county of residence as the vector of confounders L(t). As year of
invitation is a time-dependent variable, we let L(t) vary with time.
5.2 Counterfactual lifetimes
We introduce the outcome of interest as a continuous lifetime where we model
time to an event. Let T denote a non-negative random variable representing the
time from first invitation to screening until breast cancer death. All individuals in
the study population are at risk for experiencing this event at time t = 0, and by
following them over time we can register all events that happen during the study
period.
Further, consider the treatment as regular attendances to screening A∗ = 1
versus no attendances to screening A∗ = 0. Assume that each woman receive at
least one invitation and chooses to regularly attend screening A∗ = 1 or never
attend screening A∗ = 0. Let Ta
∗
be the counterfactual lifetime that would have been
observed for a woman with treatment A∗ = a∗. If Ta
∗=1 6= Ta∗=0 then treatment A∗
has a causal effect on the individual’s lifetime. The property of consistency means
that the actually observed lifetime T for an individual with screening treatment
A∗ = a∗ is equal to the counterfactual lifetime Ta
∗
.
One of the main questions when evaluating the benefit of a screening program
is exactly this, would the average lifetime of women increase if everyone attended
screening Ta
∗=1 compared to if no one attended screening Ta
∗=0. As previously
discussed, the available data only makes it possible to conduct an observational
study where we have to deal with the assumption of the identifiability conditions.
Under these assumptions, we are able to obtain any effect measure involving the
counterfactual lifetimes Ta
∗=1 and Ta
∗=0. The conditions of a well-defined treat-
ment and a positive probability of receiving the treatment still hold for the new def-
inition of screening treatment A∗. The assumption of no unmeasured confounders
will be a challenge in any observational study as we can not know if we have ad-
equately recorded information on all confounders. Hence, we will have to make
many assumptions on how these possible confounders may influence our data. In
this chapter we will behave as if the covariates available are sufficient to assume
no unmeasured confounders.
At some fixed time point t the follow up period ends, and we stop following the
women for breast cancer death. Most of the women have not experienced the event
of interest at that time, and for these women their lifetime is known to be greater
than t. In the previous chapter we defined women to be censored if they had a
missing observation. Now, we redefine the term censoring to be a time-dependent
indicator for a missing observation, where C(t) = 1 if the lifetime is censored at
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time t. When following women over time, we censor them at the time when they
are no longer under risk for experiencing the event. All individuals are uncensored
at the inclusion in the study. Individuals who die of other causes than breast cancer
will be censored at the time of death. Similarly, women who opt out of the study
or emigrate, will be censored when they exit the study. For these women, all we
know is that the uncensored lifetime T exceeds the observation time t.
5.3 Screening strategies
The screening treatment is now redefined to subsequent regular attendances ver-
sus no attendances to screening. Assume that all women receive a second invi-
tation to screening regardless of whether they attended or not at the first invita-
tion. The time of the first invitation is set to time t = 0 for all women. Since
the individuals receive subsequent invitations independently we define the time
of the j-th invitation as I j. Let A(I j) indicate the attendance at invitation number
j. Then, A(I1) = A(0) refers to the attendance at first invitation and A(I2) to the
attendance at the second invitation. The women attending screening at the first
invitation (A(I1) = 1) have the choice to continue screening (A(I2) = 1), or to stop
(A(I2) = 0). Similarly, the women not attending screening at the first invitation
(A(I1) = 0) can continue being non-screened (A(I2) = 0), or switch to attend-
ing screening at the second invitation (A(I2) = 1). When all women receive two
invitations there are four possible combinations.
In general, the women can receive more than two invitations during a follow
up period. When inviting women a number of times, there are many ways of
combining attendances and non-attendances. In fact, there are in total 2K possible
combinations when offering women K attendances. We refer to these combinations
as screening strategies A∗.
We categorize women into subgroups based on the chosen strategy at time t.
All screening strategies could be of interest when estimating the effect of screen-
ing and attendance pattern on mortality. However, we will compare breast can-
cer mortality in only two screening strategies. The one including women al-
ways attending screening A∗ = 1 where A(0) = A(I2) = ... = A(I j) = 1,
and the one including the women who never attend screening A∗ = 0 where
A(0) = A(I2) = ... = A(I j) = 0. Hence, the two valid screening strategies are;
attend screening at all invitations and never attend screening. This definition of screen-
ing strategies follows the theory of treatment regimes. When observing the atten-
dance patterns in the study population, there might be women with all kinds of
combinations of attendances and non-attendances, not only the two valid screen-
ing strategies. To deal with the multiplicity of combinations in the population,
we can introduce artificial censoring for those not following one of these screening
strategies. This means that once a woman deviate from one of the valid screening
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strategies to a non-valid regime, the woman is censored. The screening strategies
include all women from the first invitation. Those who attend at first invitation
are assigned to the screening strategy attend at all invitations and those who do not
attend at first invitation is assigned to the screening strategy never attend screening.
5.4 Data material
As we follow the women from inclusion in the study, we split the observed life-
time into time intervals initiated by a new invitation. These time units are defined
as the time period from invitation I j to the next scheduled invitation I j+1. Each
time interval is considered an observation in the data material, and the length of
each time interval varies between individuals and over time. As the median days
between two invitations are 731 days, these time intervals include on average two
years. However, there are variations in the timing of new invitations and so the
time intervals can be both shorter and longer. Each of the time intervals have in-
formation about A∗, L and V. The origin of the first interval is at a woman’s first
invitation t = 0 and lasts until the woman receives a new invitation, breast cancer
death, censoring or the end of follow up whichever come first. The second inter-
val starts at the time of the second invitation I2 and continues until the woman
receives her third invitation, breast cancer death, censoring or the end of follow
up whichever come first. The women in our study population receive up to three
invitations, and the third interval starts at the time of the third invitation I3 and
lasts until breast cancer death, censoring or end of follow up.
We want to categorize women into screening strategies based on their atten-
dance pattern, and thus we define the limit of each time interval to be 2.5 years.
Hence, women are censored when they do not receive a new invitation to the
screening program within two and a half years after the previous invitation. This
means that these women are censored 2.5 years after their previous invitation if
no new invitation is sent within that time. Any new invitation after a censoring is
excluded.
One exception is however necessary to emphasize. The administration of the
NBCSP do not invite women who have developed breast cancer after the time of
diagnosis. A woman with a breast cancer detected between invitation I j and the
next scheduled invitation I j+1, will not receive invitation I j+1, but she will not be
censored 2.5 years after invitation I j. The time interval including the breast cancer
diagnosis will run until the end of follow up or death, whichever come first. These
women are by definition following their screening strategy and is therefore still
included in the study population after the diagnosis.
Artificial censoring is implemented in the study population when a woman
changes from her initial screening strategy. At the first invitation the women select
a screening strategy and thus the women can not be artificially censored in the
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first time interval. The time interval including the first switch in attendance status
will be artificially censored, and thus excluded from the study. Any new invitation
after an artificial censoring is excluded. Artificial censoring is established in the
data after the observational study is conducted and is simply introduced such that
we can focus on the two valid screening strategies.
5.5 Structural model
We now want to specify a structural model where we can analyze the causal effect
of screening on counterfactual lifetimes. Assume we want to estimate the hazard of
breast cancer mortality in a population where all women follow screening strategy
A∗ = a∗. The hazard function is assumed to follow a Cox proportional hazard
model,
λa
∗
(t|V) = λ0(t)eβ1 A∗+β2V (3)
where λ0(t) is the baseline hazard at time t. The parameter eβ1 , corresponds to
the causal effect of screening strategy A∗ on breast cancer mortality. We assume
no model misspecification and thus consider the effect of attendance to screening
to be constant with time. We estimate the hazard of breast cancer mortality as
a function of some covariates V, included in the model. Since it is of interest to
describe the effect of screening as a function of age, we let V be age at invitation.
The contribution from each woman is weighted with inverse probability weights
described in the next section. When estimating the causal hazards on the pseudo-
population we use the robust variance estimator to calculate the 95% confidence
interval.
5.6 Individual weights
The structural Cox model (3) include counterfactual lifetimes we are unable to
observe in real data. IPW creates a pseudo-population where association is causa-
tion if there are no unmeasured confounders. A consistent estimator of the hazard
λ(t|a∗, V) in the pseudo-population is also a consistent estimator of the causal haz-
ard λa
∗
(t|V). This is possible by the method of inverse probability weighting and
we will now discuss how to correct for possible sources of bias.
We can identify three main possible sources of bias that can have an impact on
the results. First, the underlying risk of breast cancer mortality may vary between
those who choose to attend and those who choose not at the first invitation. This
is the inclusion criteria in the two screening strategies, and since attendance to
screening is optional there is a potential selection bias [19, 23]. Women with poor
health are less likely to attend screening, either because of disabilities or because of
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other concerns [24]. These women have a different risk of breast cancer death com-
pared to the healthy population. Second, the censoring due to loss of follow up is
a source of potential bias. The women who become censored due to loss of follow
up may have a different probability of attending screening and a different risk of
breast cancer death, compared to the non-censored population. We want to adjust
for possible confounders related to loss of follow up. We let C(t) be an indicator for
censoring due to loss of follow up by time t. Third, the artificial censoring might in-
troduce selection bias if there is a different risk of breast cancer death among those
who switch from one screening strategy to the other. The fact that some women
change their mind regarding attendance might be associated with a different risk
of breast cancer death compared to those adhering to one strategy throughout the
study period. Women in the strategy never attend screening who choose to initiate
screening at time t will become censored at time t. Women may be more likely to
attend if they feel a change in the breast, if they experience that someone in their
family develops breast cancer or if they start using HT. Similarly, one might think
that women who stop attending at time t have a different breast cancer risk than
those who choose to continue the strategy. We define N(t) to be an indicator for
artificial censoring by time t. The two types of censoring, loss of follow up and
artificial censoring, are caused by two different mechanisms. Thus we correct for
the selection bias by two separate sets of IPW for dealing with censoring.
We define TC=0 to be the counterfactual lifetimes in the population if no one
was censored due to loss of follow up. We are only interested in the counterfactual
lifetimes where no one is censored because we do not want censoring to introduce
bias to the data. The counterfactual lifetimes TA
∗=a∗ where all women follow the
screening strategy A∗ = a∗ include only those adhering to one screening strategy
at time t such that N(t) = 0. We let Ta
∗ ,c be the lifetimes in a population where
all women follow screening strategy A∗ = a∗ and where everyone is selected with
C = c. Typically, we are interested in TA
∗=1,C=0 versus TA
∗=0,C=0 which are life-
times for screened and non-screened women in populations where no one is lost
to follow up and everyone follows one of the screening strategies.
We assume consistency so that the observed lifetime T for a woman following
the screening strategy A∗ = a∗ with C = 0 is equal to the counterfactual lifetime
TA
∗=a∗ ,C=0. Thus, we can estimate the counterfactual hazard λc,a
∗
(t|V) by estimat-
ing λ(t|A∗ = a∗, C = 0, V = v) in a pseudo-population where the weights are
based on the probabilities of choosing the specific screening strategy, not being
censored due to loss of follow up and artificial censoring.
5.6.1 Confounders
We now want to derive the IPW for correcting for bias due to choosing screening
strategy. Consider a woman in our study population, invited to screening for the
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first time. She can choose either of the screening strategies, depending on her
choice of attending at this invitation. This selection bias between the two screening
strategies is present at the first invitation only. By including the variables that
might have an effect on attendance to screening and breast cancer death in the
vector L at time t = 0, we can obtain conditional exchangeable groups regarding
this selection.
The inverse probability weights for correcting for confounders are given as
WA
∗
(0) =
1
Pr{A∗(0) = 1|L, V}
The denominator is the individual probability of attending screening at time t = 0
given the predictors V and confounders L. As earlier described, we can stabilize
the weights by multiplying with the probability of attending screening given V,
SWA
∗
(0) =
Pr{A∗(0) = 1|V}
Pr{A∗(0) = 1|L, V} . (4)
By these weights we are able to correct for variables that possibly have an ef-
fect on the selection of screening strategy and breast cancer death, assuming we
have no unmeasured confounders. Once the women have chosen to attend or not
attend at their first invitation, the women are included in one of two screening
strategies. SWA
∗
(0) only correct for the difference at time t = 0 between those
choosing each of the screening strategies. Differences between women attending
and not attending at subsequent invitations will be corrected for by using weights
for artificial censoring because a change in screening strategy is handled by artifi-
cial censoring. The factors of SWA
∗
(0) defined in (4) can be estimated by fitting a
logistic regression model where we specify the outcome of interest as attendance
at the first invitation, and we include the predictors as described. Based on the re-
sulting estimates we can calculate the probability of following screening strategy
A∗, given L and V.
5.6.2 Censoring due to loss of follow up
Consider a woman not previously censored who is invited to screening at time I j
where we have recorded her chosen screening strategy A∗ and the vectors L and V.
This woman can exit the study throughout the time interval (I j, I j+1), and she will
be censored due to loss of follow up after this time interval. Based on the values
of A∗, L and V, we can predict the probability of her being censored at time I j+1.
The women can not be censored due to loss of follow up in the third and last time
interval (I3, ) because no women receive a fourth invitation in the study material,
and all individuals are followed throughout the study period.
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The women are weighted with the inverse probability of being in the actually
observed censoring group. We use the observations from a woman’s first time
interval to model the probability of her not being censored at the next invitation.
If the woman receives a new invitation within 2.5 years after her first invitation,
she is not censored and we follow her through her second time interval. We use
information about the second time interval to estimate the probability of not being
censored at the third invitation.
The inverse probability weights for censoring can be written as
WC(I j) =
1
∏ jk=1 Pr{C(Ik+1) = 0|C(Ik) = 0, N(Ik) = 0, A∗, L¯(Ik), V}
for j ≥ 1.
The denominator is the individual probability of remaining uncensored at time
I j given that the woman is not censored for any reason up to that time point, the
screening strategy A∗, a set of confounders L and the predictor V. We have also
included time-varying confounders L¯(I j) which include factors that change over
time. The overbar notation denote the history of the variable up to time I j includ-
ing the baseline confounders. Year of invitation may be such a time-dependent
confounder because trends in the population may alter the probability of opting
out of the screening program.
We use the product of probabilities because we condition on not being censored
up to the current time interval. A woman’s probability of not being censored at the
third invitation is calculated as the product of the probability of not being censored
for any reason at the first and the second invitation. This include the fact that all
women adhere to one of the two screening strategies, such that A∗ is either attend
screening at all invitations or never attend screening. We can stabilize the weights by
multiplying with the probability of not being censored up to time I j given A∗ and
V.
SWC(I j) =
∏ jk=1 Pr{C(Ik+1) = 0|C(Ik) = 0, N(Ik) = 0, A∗, V}
∏ jk=1 Pr{C(Ik+1) = 0|C(Ik) = 0, N(Ik) = 0, A∗, L¯(Ik), V}
for j ≥ 1.
(5)
Based on the probabilities described in (5) we can calculate the individual
weight for censoring due to loss of follow up at time I j
SWC(I j) =

j
∏
k=1
Pr(C(Ik+1) = 0|A∗, V)
Pr(C(Ik+1) = 0|A∗, V, L) if C(I j) = 0
j
∏
k=1
Pr(C(Ik+1) = 1|A∗, V)
Pr(C(Ik+1) = 1|A∗, V, L) if C(I j) = 1
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The numerators and the denominators of SWC(I j) can be estimated by fitting
separate logistic regression models where the outcome is being censored due to
loss of follow up C(t), adjusted for A∗, L and V. We fit one model for each time
interval separately, such that the estimated probabilities at time I j are based on
all observations done in the time interval (I j−1, I j). This means that all women
contribute with observed time in each regression model given that they are not
censored up to this time point. The predicted probabilities of being censored are
estimated by inserting the individual values of A∗, L and V into the model.
5.6.3 Artificial censoring
Artificial censoring is implemented to deal with combinations of attendances and
non-attendances different from the two predefined valid screening strategies. Con-
sider a woman not previously censored who is invited to screening at time I j for
any j > 1. We will artificially censor her at time I j if she switches from her valid
screening strategy at invitation I j. We use the recorded values of the vectors L and
V from her previous invitation I j−1, together with the screening strategy A∗ at the
previous invitation I j−1. Based on the values of A∗, L and V from time interval
I j−1, we can predict the probability of being artificially censored at time I j.
Women are at risk for being artificially censored from time I2. At this time point,
the women have chosen a screening strategy and if they are not censored due to
loss of follow up, they will receive their second invitation. The probabilities used
in the IPW must therefore condition on not being censored due to loss of follow up
at time I j and not being artificially censored up to that time point. Thus, we derive
the weights for artificial censoring as
WN(I j) =
1
∏ jk=1 Pr{N(Ik) = 0|C(Ik) = 0, N(Ik−1) = 0, A∗, L¯(k), V}
for j ≥ 2.
The denominator is the individual probability of remaining in the screening strat-
egy at time I j given that the woman is not censored for any reason up to that
time point, the screening strategy A∗, the time-varying confounders L¯(I j) and co-
variates V. Similarly as before, we use the product of probabilities because we
condition on multiple following events.
The weight WN(I j) is 1 for all women in the first time interval because no
woman is artificially censored in this time interval. The weights in the second time
interval is defined as the inverse of the probability that a woman does not switch
from her screening strategy at the second invitation, given a set of covariates in the
first time interval and given that she actually receives a second invitation. At the
third invitation, WN(I j) is calculated as the product of the inverse probabilities of
her following the same screening strategy at invitation number 2 and 3, given a set
of covariates and given that she receives three invitations.
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We can stabilize the weights by multiplying with the probability of not being
artificially censored up to time I j given A∗ and V.
SWN(I j) =
∏ jk=1 Pr{N(Ik) = 0|C(Ik) = 0, N(Ik−1) = 0, A∗, V}
∏ jk=1 Pr{N(Ik) = 0|C(Ik) = 0, N(Ik−1) = 0, A∗, L¯(Ik), V}
for j ≥ 2
(6)
Similarly as for SWC(I j) we can calculate the individual weight for artificial
censoring defined in (6) at time I j
SWN(I j) =

j
∏
k=1
Pr(N(Ik) = 0|A∗, V)
Pr(N(Ik) = 0|A∗, V, L) if N(I j) = 0
j
∏
k=1
Pr(N(Ik) = 1|A∗, V)
Pr(N(Ik) = 1|A∗, V, L) if N(I j) = 1.
The numerators and the denominators of SWN(I j) can be estimated by fitting
separate logistic regression models where the outcome is being artificially censored
N(t), adjusted for A∗, L and V. We fit one model for each time interval separately,
such that the estimated probabilities at time I j are based on all observations done
in the time interval (I j−1, I j) for j > 1. This means that all women contribute with
observed time in each regression model given that they are not censored up to this
time point.
5.6.4 Creation of a pseudo-population
We have now defined three sets of inverse probability weights, one for correction
for bias due to selection of screening strategy, and two for correcting for bias due
to censoring. To create the pseudo-population we calculate one common weight
for all sets of IPW for each woman. This weight is defined as SWA
∗
(0) · SWC(I j) ·
SWN(I j) and depend on time as a function of invitations.
SW(t) =

SWA
∗
(0) · SWC(Ii1) if Ii1 ≤ t < Ii2
SWA
∗
(0) · SWC(Ii1) · SWC(Ii2) · SWN(Ii2) if Ii2 ≤ t < Ii3
SWA
∗
(0) · SWC(Ii1) · SWC(Ii2) · SWN(Ii2) · SWN(Ii3) if Ii3 ≤ t
Finally, when SW(t) is estimated we can use these weights to estimate the
causal hazards λa
∗
(t|V). This is done by fitting an inverse probability weighted
Cox proportional hazards model with screening strategy A∗ and the predictor V.
Assuming there is no model misspecification and no unmeasured confounders we
can calculate the effect of screening on breast cancer mortality.
51
5 APPLICATION TO SCREENING DATA
5.7 Results
We have information about 521 411 women invited to screening in the available
data material. The follow up time for these women are split into time intervals,
including information about the number and order of the invitation, the screening
strategy, the age and the year of the current invitation. In addition, we record the
residing county at inclusion in the study, date of breast cancer diagnosis and the
date of death or emigration for all women in the study.
Table 3: Number of women, total time on risk for breast cancer death, number of breast cancer
cases and mortality rates per 100 000 women years, by women regularly screened and women
never screened.
Number of
women
Women
years
(wy)
Number of
breast cancer
deaths
Mortality
rates per
100 000 wy
Non-screened 122 658 648 072 286 44.1
Screened 398 753 3 308 752 686 20.7
Total 521 411 3 956 824 972 24.6
In total, the uncensored follow up time is 3 956 824 women years (Table 3). The
number of breast cancer deaths divided by the total time at risk for the women
following the screening strategies are crude estimates of the breast cancer mor-
tality in the two groups. Those women never attending screening have a mortality
rate of 44.1 per 100 000 women years, and those women attending screening at all
invitations have a mortality rate of 20.7 per 100 000 women years. The estimated
crude mortality rate ratio is 0.47 (20.7/44.1) comparing the screened and the non-
screened women. This rate ratio indicate a 53% (1-0.47) reduction in breast cancer
mortality among the screened women compared to the non-screened. We will now
use these data to estimate the causal effect of screening on breast cancer mortality
under the assumptions of conditional exchangeability and the identifiability condi-
tions. In order to make the women in the two screening strategies conditionally ex-
changeable, we include inverse probability weighting described in section 4.4 and
section 5.6. The weights will compensate for differences between the women reg-
ularly screened and the women never screened, such that the groups are compa-
rable. We will now describe how we obtain the sets of inverse probability weights
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such that the screening strategies are assumed to be comparable.
At first invitation, the women choose which screening strategy to follow
throughout the study period. If we are able to adjust for all confounders related to
choosing screening strategy and breast cancer death, we can eliminate this bias. In-
cluding only the first time interval for each woman, we can include age and year of
first invitation and county of residence as confounders and fit a logistic regression
model with screening attendance as the binary outcome. This logistic regression
model is the exact same as described in section 3.3 for the first invitation only and
will be used to calculate the stabilized IPW described in (4). The potential source
of bias is current in each time interval, although the effect does not changes over
time. Hence, we use only the first time interval for each woman to fit the logistic
model and thus weight each time interval with the weights calculated at baseline.
A summary of the weights is given in Table 4.
Second, we want to adjust for bias related to censoring due to loss of follow up
(5). The probability of censoring may be different in the two screening strategies
and by adjusting for this difference we hope to eliminate this bias. The women in
the study population can be censored due to loss of follow up in each time interval,
and the final weight is a product of conditional probabilities of not being censored.
We fit one model for each combination of invitation number and screening strategy,
adjusted for age at the invitation V and the year of the current invitation and the
county of residence L(t). The results of the models are described in the appendix
section A.2. The final weights WC(I j) and SWC(I j) are computed as a product
of the inverse probabilities described. The mean and standard deviation of the
weights are given in Table 4.
Table 4: A summary of non-stabilized and stabilized IPW for attendance at first invitation
(WA
∗
(0), SWA
∗
(0)), censoring due to loss of follow up (WC(I j), SWC(I j)) and artificial censoring
(WN(I j), SWN(I j))
Non-screened Screened Total
Non-stable Stable Non-stable Stable Non-stable Stable
mean (sd) mean (sd) mean (sd) mean (sd) mean (sd) mean (sd)
WA
∗
(0) 4.22 (1.53) 0.99 (0.36) 1.30 (0.14) 1.00 (0.11) 1.85 (1.33) 1.00 (0.18)
WC(I j) 1.90 (3.58) 1.00 (0.14) 2.05 (26.85) 1.00 (0.28) 2.02 (24.25) 1.00 (0.26)
WN(I j) 1.32 (0.36) 1.00 (0.08) 1.09 (0.09) 1.00 (0.03) 1.13 (0.20) 1.00 (0.043)
W(I j) 10.24 (21.54) 1.00 (0.40) 2.91 (40.23) 1.00 (0.32) 4.29 (37.55) 1.01 (0.33)
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The last set of inverse probability weights is made to adjust for bias caused by
artificial censoring. This censoring is present at the second and third invitation
only, and we will use the covariates known at a woman’s first time interval to
estimate the probability of her switching screening strategy at her next invitation.
This is conditional on her actually receiving a new invitation. The equation of
SWN condition on status of censoring at the current time interval, status of artificial
censoring at the previous invitation, screening strategy, confounders L(t) and the
predictor V(6). We use the same set of covariates as for WC(I j) and SWC(I j), and
fit logistic regression models described in the appendix section A.2.
Now, we have described how to use logistic regression to estimate the IPW
for attendance at first invitation, censoring due to loss of follow up and artificial
censoring. Together, we assume that the three sets of weights will correct for any
bias related to these factors. We multiply the individual weights such that we get
one common weight for all three factors,
W(I j) = WA
∗
(0) ·WC(I j) ·WN(I j)
SW(I j) = SWA
∗
(0) · SWC(I j) · SWN(I j).
5.7.1 Mortality rate ratios
The women in the data material are now individually weighted to create a pseudo-
population. By doing so, we are able to estimate the causal effect of screening
attendance on breast cancer mortality. To get a first view of the distribution of
the data we compute Nelson-Aalen estimates for three different weighting pro-
cedures (Figure 6). The leftmost sub-figure shows the situation where everyone
is equally weighted, the center sub-figure uses the non-stabilized weights W(I j),
and the third sub-figure uses the stabilized weights SW(I j). The effect of screen-
ing in all three of the populations show a consistently higher risk of breast cancer
death for non-screened women compared to screened women over time. There is
little difference between the three weighting procedures in the estimated hazards
for breast cancer mortality. This indicates that the method of inverse probability
weighting does not alter the results significantly. Thus, the variables adjusted for
in the IPW do not introduce much bias in our data.
We now fit the Cox proportional hazard model described in section 5.5 on the
original population, and the two pseudo-populations(Table 5). The estimated haz-
ard ratios (HR) for breast cancer mortality for the women following the two screen-
ing strategies are 0.38, 0.41 and 0.37 in favour of the regularly screened women, in
the original population, the non-stabilized weighted and the stabilized weighted
pseudo-population, respectively. The result from the stabilized weighted pseudo-
population is our best approximation for the estimated screening effect. With this
weighting procedure, the reduction in breast cancer mortality is estimated to be
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Figure 6: Nelson-Aalen estimates of the hazard rates for breast cancer mortality among women
following the two screening strategies, for the three weighting procedures. The leftmost figure is
for the situation of no use of IPW, the center figure is for the situation with non-stabilized weights
and the rightmost figure is for the situation with stabilized weights.
63% (1-0.37) among the women following the screening strategy attend screening at
all invitations compared to the women following the screening strategy never attend
screening. The results obtained with the different weighting procedures are very
similar. This indicates that the variables available introduce little bias between the
comparison groups. The effect of age is borderline significant when using the three
weighting procedures. The effect of a 10 years increase in the original population
corresponds to a reduced breast cancer mortality of 18% (1− e−0.02∗10). In the two
pseudo-populations the effect of age is not statistically significant. Since age is in-
cluded in the model for IPW, some of the effect of age might be corrected for in the
weighting procedure.
We have shown a large effect of mammographic screening on breast cancer
mortality when assuming that we can correct for any bias using the method of IPW.
The results do not differ with each of the weighting procedures, and we conclude
that the variables available do not introduce much bias in the data. Even so, we
believe that there are underlying differences in the regularly screened women and
the women never screened that we are unable to correct for in the data available.
It is possible that the difference between the original and the pseudo-population
would be larger if we could include more variables into the confounder L. Since
we do not have more covariates available of today, we will not be able to do this,
but we can use data available to get an idea of the underlying differences. In the
next chapter we will use information on overall mortality and questionnaire data
55
5 APPLICATION TO SCREENING DATA
Table 5: Cox regression model for breast cancer mortality in the three pseudo-populations, using
equal weights, using non-stabilized weights (W) and using stabilized weights (SW). Age at invita-
tion is included in the model as the only predictor.
Coef RobustStd.Err. p-value
Hazard
Ratio
95 % CI
for HR
Equal
weights
Screened 0.00 1.00
Non-screened -0.97 0.07 <0.001 0.38 0.33 0.43
Age -0.02 0.01 0.018 0.98 0.97 1.00
W
Screened 0.00 1.00
Not-screened -0.90 0.11 <0.001 0.41 0.33 0.51
Age 0.02 0.01 0.146 1.02 0.99 1.05
SW
Screened 0.00 1.00
Not-screened -1.00 0.07 <0.001 0.37 0.32 0.43
Age -0.01 0.01 0.066 0.99 0.97 1.00
and look for differences between the comparison groups. We will also discuss
how strong the underlying difference must be in order to eliminate the estimated
hazard ratio calculated in this chapter.
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Chapter 6
Sensitivity analysis
In the previous chapter we estimated the effect of mammographic screening on
breast cancer mortality for the data currently available. The quality of this esti-
mate rely on the assumption of the identifiability conditions. The data available
contain a lack of unmeasured confounders, and thus we are unable to find the true
effect of mammographic screening. In this chapter we will briefly discuss how
the results may be affected by unmeasured confounders and how strong such con-
founders need to be, in order to alter our results significantly. We have suggested
that the regularly screened women are more healthy than the women never attend-
ing, and so we can compare the overall mortality for all causes of death for the two
groups. Studying overall mortality can reveal underlying differences in general
health conditions. As the number of breast cancer deaths in the data material are
small compared to the total number of deaths, the groups will have similar risks
of death if there are no underlying difference between the two groups. We will
also discuss how questionnaire data from the NBCSP can be used as a third op-
tion for describing differences between the women screened and the women never
screened.
6.1 Sensitivity analysis for unmeasured confounding
A difference between the women regularly screened and the women never
screened is observable from the time of the first invitation. We are interested in
any underlying difference that cause the screened women to attend, or that cause
the non-screened women to not attend at the first invitation. The focus of this sec-
tion is not to explain which factors may be included in the underlying difference,
but how strong this difference must be to eliminate the estimated effect of mam-
mographic screening. We can think of the total difference as the healthy screening
effect including any measurable or unmeasurable variables. The sensitivity analy-
sis aim at studying the effect of the underlying difference on the estimated hazard
ratio. We run the analysis on the pseudo-population where we have corrected for
as much of the bias as possible with the variables available. We will now introduce
a method to study the magnitude of selection bias and the effect on the hazard
ratio [25, 26]. We present and apply the method described by Klungsøyr et. al [26]
where standardization is used to correct for measured confounders in stead of IPW.
A standard definition of a hazard rate can be written as
λ(t) = lim
dt→0
1
dt
Pr(T ∈ [t, t + dt)|T ≥ t).
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Thus we can heuristically write the causal hazard ratio of breast cancer mortality
among the regularly screened women and the women never screened as
λa
∗=1(t|V)
λa
∗=0(t|V) =
Pr(Ta
∗=1 ∈ [t, t + dt)|Ta∗=1 ≥ t, V = v)
Pr(Ta∗=0 ∈ [t, t + dt)|Ta∗=0 ≥ t, V = v) =
λ0(t)eβ1+β2V
λ0(t)eβ2V
= eβ1 (7)
First, we define a function u(a∗, l, v) that describes the lack of exchangeability
between the women in the two screening strategies,
u(a∗, v, l) = Pr(T
a∗ ∈ [t, t + dt)|Ta∗ ≥ t, A∗ = a∗, V = v, L = l)
Pr(Ta∗ ∈ [t, t + dt)|Ta∗ ≥ t, A∗ = 1− a∗, V = v, L = l) . (8)
This function describes the relationship between the counterfactual lifetimes Ta
∗
for women regularly screened and women never screened. Under exchangeabil-
ity, u(a∗, v, l) is equal to 1, and the women regularly screened and the women never
screened have the same risk of breast cancer mortality when they have equal treat-
ment. The greater the value differs from 1, the greater is the lack of exchangeabil-
ity. We will use this quantity to express the difference in breast cancer mortality
among the women in the two screening strategies if they had been treated with
the same treatment. A value of u(a∗ = 1, v, l) < 1 indicate that the causal haz-
ard rate for women regularly screened is lower than the causal hazard rate for
women never screened, when all women attend screening regularly. Similarly,
if u(a∗ = 0, v, l) < 1 indicate that the causal hazard rate for women regularly
screened is lower than the causal hazard rate for women never screened, when no
women attend screening.
Under the assumption of proportionality in the Cox model, the hazard ratio is
constant over time. Thus, we can let t→ 0 in (8) and write u(a∗, v, l) as
u(a∗, v, l) = Pr(T
a∗ ∈ [0, dt)|A∗ = a∗, V = v, L = l)
Pr(Ta∗ ∈ [0, dt)|A∗ = 1− a∗, V = v, L = l) .
Using this assumption, we can write the numerator and the denominator of (7) as
Pr(Ta
∗ ∈ [0, dt)|V = v) =∑
l
Pr(Ta
∗ ∈ [0, dt)|V = v, L = l)Pr(L = l|V = v)
=∑
l
[Pr(Ta
∗ ∈ [0, dt)|A∗ = a∗, V = v, L = l)
× Pr(A∗ = a∗|V = v, L = l)Pr(L = l|V = v)
+ Pr(Ta
∗ ∈ [0, dt)|A∗ = 1− a∗, V = v, L = l)
× Pr(A∗ = 1− a∗|V = v, L = l)Pr(L = l|V = v)]
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=∑
l
[Pr(Ta
∗ ∈ [0, dt)|A∗ = a∗, V = v, L = l)
× Pr(A∗ = a∗|V = v, L = l)Pr(L = l|V = v)
+ Pr(Ta
∗ ∈ [0, dt)|A∗ = a∗, V = v, L = l)
× Pr(T
a∗ ∈ [0, dt)|A∗ = 1− a∗, V = v, L = l)
Pr(Ta∗ ∈ [0, dt)|A∗ = a∗, V = v, L = l) ]
× Pr(A∗ = 1− a∗|V = v, L = l)Pr(L = l|V = v)
=∑
l
Pr(Ta
∗ ∈ [0, dt)|A∗ = a∗, V = v, L = l)
{
Pr(A∗ = a∗|V = v, L = l)+
1
u(a∗, v, l)
Pr(A∗ = 1− a∗|V = v, L = l)
}
× Pr(L = l|V = v)
=∑
l
Pr(Ta
∗ ∈ [0, dt)|A∗ = a∗, V = v, L = l)ka∗(u, v, l)Pr(L = l|V = v)
=∑
l
Pr(T ∈ [0, dt)|A∗ = a∗, V = v, L = l)ka∗(u, v, l)Pr(L = l|V = v)
where
ka∗(u, v, l) = Pr(A∗ = a∗|V = v, L = l) + 1u(a∗, v, l)Pr(A
∗ = 1− a∗|V = v, L = l).
By using these results we can modify (7) to include ka∗(u, v, l) like this,
eβ
′
1 =
∑l Pr(Ta
∗=1 ∈ [0, dt)|A∗ = 1, V = v, L = l)k1(u, v, l)Pr(L = l|V = v)
∑l Pr(Ta
∗=0 ∈ [0, dt)|A∗ = 0, V = v, L = l)k0(u, v, l)Pr(L = l|V = v) . (9)
Now, we need to define a functional form of u(a∗, v, l) such that it describes
the causal hazard ratio of breast cancer mortality in the women regularly screened
compared to the women never screened if everyone attend screening regularly,
u(a∗ = 1, v, l) = Pr(T
a∗=1 ∈ [0, dt)|A∗ = 1, V = v, L = l)
Pr(Ta∗=1 ∈ [0, dt)|A∗ = 0, V = v, L = l) .
By the definition of consistency, the numerator is equal to the breast cancer mortal-
ity observed among the screened women. The denominator is the counterfactual
breast cancer mortality among the women never screened if they attend screen-
ing regularly. Our hypothesis is that the screened women are a selected group of
healthy women, and so we expect that the non-screened women have a higher
breast cancer mortality than the screened women, even if both groups had at-
tended screening regularly. We propose a constant factor representing this selec-
tion, regardless of values of V and L,
u(a∗ = 1, V = v, L = l) = 1
α
forα > 1 and all v, l
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Similarly, the causal hazard ratio of breast cancer mortality for women in the two
screening strategies if no one attend screening, can be written as
u(a∗ = 0, V = v, L = l) = Pr(T
a∗=0 ∈ [0, dt)|A∗ = 1, V = v, L = l)
Pr(Ta∗=0 ∈ [0, dt)|A∗ = 0, V = v, L = l) .
The numerator is now the counterfactual breast cancer mortality among the
screened women if they had not attended screening. The denominator is, by con-
sistency, the observed breast cancer mortality among the non-screened women. It
is plausible to assume that this ratio is equal to the factor u(a∗ = 1, V = v, L = l),
such that the factor is equal if everyone attend screening regularly and if no one
attend screening. Hence, we can define
u(a∗ = 0, V = v, L = l) = 1
α
forα > 1 and all v, l
The functional form of u(a∗, l, v) is defined as a constant, and we simplify the pa-
rameter to u(α). By (9) we can write the hazard rate λ(t|A, V) as a function of
λ′(t|A, V),
λ′(t|A∗, V) = λ′0(t)eβ
′
1 A
∗+β2V = λ(t|A∗, V)elog kA∗
λ(t|A∗, V) = λ′0(t)eβ
′
1 A
∗+β2V−log kA∗
where λ′(t|A∗, V) is the hazard rate of breast cancer mortality adjusted for mea-
sured and unmeasured confounders. We can estimate β′1 by fitting a Cox propor-
tional hazard model of the form
λa
∗
(t|V) = λ′0(t)eβ
′
1 A
∗+β2V−log kA∗
This is done by including log kA∗ as an offset when fitting the Cox model. The esti-
mated parameter β′1 is an adjusted hazard ratio for breast cancer mortality among
women regularly screened and women never screened. Now that we have sug-
gested a functional form of u(α), we let α vary from 1 to 11 and fit the modified
Cox proportional hazard model to the pseudo-population (Figure 7). The figure
illustrate how the adjusted hazard ratio is changed with a reduction of u(α), from
1 to 1/11. When u(α) equals 1, we assume exchangeability which was done in the
previous chapter where we estimated the hazard rate ratio to be 0.37. By increas-
ing the lack of exchangeability between the two screening strategies, we reduce
the estimated effect of screening. When α = 7 and u(α) = 1/7, then the adjusted
hazard ratio is not statistically significantly different from 1. This means that as-
suming there is an underlying factor that decreases the risk of breast cancer death,
it must be 7 times stronger among the women regularly screened compared to the
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Figure 7: Adjusted hazard ratios of breast cancer mortality for different degrees of unmeasured
confounding, between screened and non-screened women
women never screened, before we conclude that mammographic screening has no
effect on breast cancer mortality. Thus, the healthy screening effect must reduce
breast cancer mortality with a factor of 7 in order for the true effect of mammo-
graphic screening to be eliminated. The function u(α) can be of any form, and in
this example we have used a constant α. However, if we think that the selection
bias change over time, age groups or between counties, we could include L or V in
the functional form of u(a∗, l, v).
6.2 Overall mortality
Another way of studying the underlying difference between the screened and the
non-screened women are by studying the overall mortality, including all causes of
death as the outcome of interest.
We use the same data material as described in chapter 5, using the stabilized
inverse probability weights for the pseudo-population, where we have corrected
for as much of the bias as possible with the variables available. By computing a
Nelson-Aalen estimate based on the women in the two screening strategies, we can
get an overview of the cumulative hazard of overall mortality (Figure 8). The fig-
ure shows a large difference in overall mortality for women regularly screened and
women never screened. This indicates a large selection bias between the groups,
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where the non-screened women have a higher risk of death from all causes com-
pared to the screened women. Further, we fit a Cox proportional hazard model for
overall mortality in the pseudo-population, adjusted for age. The estimated hazard
ratio is 0.26 (95%CI: 0.25-0.26) for overall mortality comparing the two screening
strategies. The non-screened women have a 74% (1-0.26) higher risk of all-cause
death compared to the screened women. The estimated hazard ratio of overall
mortality of 0.26 corresponds to a 3.8 (1/0.26) times higher risk of all-cause death
among the women never screened compared to the women regularly screened. In
fact, these findings account for a healthy screening effect, where women choosing
to attend screening have a healthier behaviour, are more health aware, seek med-
ical care more often or are more likely to comply with proposed treatment when
diseased, compared with those choosing to not attend screening. Which factors
this effect represents, is not obvious, but we can assume that there is a substantial
amount of selection bias that have an impact on the estimation of the screening
effect when we have unmeasured confounders.
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Figure 8: The Nelson-Aalen estimates of the hazard rates for overall death among women following
the two different screening strategies
6.3 Using questionnaire data
A third way to study the difference between the women following the two screen-
ing strategies are by comparing the distribution of possible risk factors for breast
cancer death in the two groups. As previously mentioned, we can not correct for
these variables with the data currently available, and so we struggle to claim condi-
tional exchangeability. The NBCSP questionnaire described in section 2.3 includes
a large number of the covariates that could reduce this limitation. However, as the
questionnaire is only completed by the women attending screening, we are unable
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to adjust for these covariates. By using what we know about the general popula-
tion, and the available information from the questionnaire data, we can get an idea
of the distribution of the confounders for the women attending screened at least
once and the women never screened. We want to use all data available from the
questionnaire, and thus we categorize women who have attended and responded
to the questionnaire at least once, as an approximation of screened women. This
comparison is not fully in agreement with the defined screening strategies, and
can not be directly compared with previous comparisons of the women regularly
screening and the women never screened. Not all women who attend screening
complete the questionnaire, and not all completed questionnaires include a valid
response to this particular question.
We will now present the data available on use of hormonal therapy for the
women screened and the general population. The information on how many
women residing in Norway aged 50-69 and how many of these are using hormonal
therapy are registered in the Norwegian Prescription Database since 2004 [27].
These aggregated data are available on-line. We can now compare the percentage
of women using hormonal therapy in the general population and the percentage
of women responding a use of hormonal therapy among women screened. Ideally,
this can give us a perspective of the difference between women screened at least
once and the women never screened, with respect to use of hormonal therapy.
Table 6: Number of women in the female population aged 50-69 and the number of women using
hormonal therapy in the period 2004-2009. For comparison, number of screened women, number
of questionnaire responses and number of self-reported users of hormonal therapy, in the same
population in the period 2004-2009.
General Population Women Questionnaire
Year Total HT users Screened Total HT users
(n) (n) (%) (n) (n) (n) (%)
2004 497178 121858 24.5 177819 58270 23642 40.6
2005 509058 113327 22.3 181653 29802 12283 41.2
2006 521396 110735 21.2 188634 66066 18756 28.4
2007 532816 109512 20.6 184588 142279 34188 24.0
2008 543948 108897 20.0 193167 149981 40740 27.2
2009 554792 109944 19.8 195049 148974 39314 26.4
Total 3159188 674273 21.3 1120910 595372 168923 28.4
Among the women in the target population of the screening program, on av-
erage 21.3% use hormonal therapy in the period 2004-2009 (Table 6). Based on the
self-reported questionnaire data, on average 28.4% of the women who have com-
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pleted at least one questionnaire, respond that they are currently using hormonal
therapy. In 2004, 40.6% of the women screened responded a current use of HT,
whereas 24.5% of the general population used HT. The results indicate a dramatic
change over time, in women responding the questionnaire and in the general pop-
ulation. The difference between these two groups has decreased with time, but
the results show a generally higher use of HT among women screened compared
to the general population. Due to implementation of new questionnaire forms in
2006, the response rates differ between the years. In 2005 16% of the screened
women did respond to a questionnaire, whereas 78% of the screened women in
2008 responded a similar form. Among the women registered with a question-
naire, the missing rates for the specific question on use of HT ranged from 5% in
2004 to 25% in 2009. However, the results indicate that the screened women use,
on average more hormonal therapy compared to the women never screened. This
coincide with the assumption that women who are using hormonal therapy are
more health aware and likely to visit the general practitioner more frequently than
women not using hormonal therapy. They might be advised from the health au-
thorities to attend screening and be aware of their increased risk of breast cancer.
There are many covariates included in the questionnaire, that we would like to
study in the same way as for use of HT. However, information on most of these
covariates are not available on-line, for women aged 50-69 in our study period.
Median age at first birth for women born in the period 1936-1960 is published by
Statistics Norway [28]. This variable is a possible confounder for attendance to
screening and breast cancer death, and is also available from the questionnaire
data.
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Figure 9: Median age at first birth for screened
women (solid line, reported 2006-2009) and for
the general population (dashed line, observed),
by women’s birth cohort.
However, continuous age at first
birth is only available from the
updated questionnaire forms, and
thus we use only questionnaires
collected in the period 2006-2009
to study this parameter (see sec-
tion 2.3 for details). The median age
for the screened women are on av-
erage one year lower than the me-
dian age in the general population,
indicating that screened women are
younger when they give birth for
the first time (Figure 9). A low age
at first birth is associated with a de-
crease in risk of breast cancer, in-
dicating that the screened women
have a lower risk of breast cancer
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compared to the general population, when looking at this variable separately.
We have now tried to use available data to understand differences between
the women following the screening strategies by comparing the women never
responding the questionnaire to those responding a questionnaire at least once.
This comparison is not necessarily what we are interested in, but it may give us a
perspective of the distribution of risk factors. Another approach using the ques-
tionnaire data is to let the women attending screening be the reference, and then
study if there is a difference among those attending at the next invitation, and those
choosing not to attend at the next invitation. We have compared several variables
included in the questionnaire and the results are shown in Table 7. The percent-
ages are calculated among those who answered each question, and the missing
rates of each question are added in gray. The two groups are very similar for most
of the parameters. For smoking habits, 13% of the women not attending at the next
invitation report smoking daily and 9% of the women attending at the next invita-
tion report the same habit. Among the women not attending at the next invitation
a lower number report using HT (34%), a lower number report to drink alcohol
(78%) and a higher number are younger that 20 years at first birth (21%) versus the
women attending at the next invitation, where 38% report using HT, 82% report to
drink alcohol and 17% report that they were below 20 years at first birth.
This chapter presents ideas and thoughts of differences between attendees and
non-attendees. We can not reach a conclusion on underlying differences, neither
the magnitude nor the covariates explaining the differences. Nevertheless, we
have indications that differences exist and that some variables are distributed dif-
ferently between the groups. The overall mortality is higher for the women never
screened compared to the women regularly screened. We assume that the women
screened have a better general health compared to women never screened. This
will result in an overestimated effect of mammographic screening. We have shown
that a possible healthy screening effect needs to be 7 times stronger in women
screened compared to non-screened in order to eliminate the effect of mammo-
graphic screening. We have looked at distributions of variables that can be in-
cluded in this common unmeasured confounder. Use of HT is higher among
women screened, and will increase the risk of breast cancer in this group. We
do not know if this has an effect on breast cancer mortality, but if that is true, the
effect of mammographic screening is underestimated with respect to this variable.
Self-reported age at first birth is slightly lower in women screened compared to
the general population, and we assume that it does not have a strong effect on the
estimation of breast cancer mortality. Further, we have found no strong indications
of differences in additional risk factors for women attending at the next invitation
versus women not attending at the next invitation.
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Table 7: The distribution of risk factors for breast cancer among women attending and completing
at least one questionnaire, categorized by the attendance status at the next invitation to screening,
1996-2009.
Not Attend
at next invitation
Attend
at next invitation Total
(n) (%) (n) (%) (n)
Education
Secondary school 25732 30% 207613 30% 233345
High school 33881 40% 289632 42% 323513
Higher education 25224 30% 185288 27% 210512
Missing 61191 42% 516990 43% 578181
Current Smoker
Never 114140 84% 991558 88% 1105698
Rarely 1810 1% 14466 1% 16276
Occasionally 2521 2% 18697 2% 21218
Daily 17560 13% 106669 9% 124229
Missing 9997 7% 68133 6% 78130
Alcohol consumption
Yes 102178 78% 900957 82% 1003135
No 28866 22% 196144 18% 225010
Missing 14984 10% 102422 9% 117406
Hormonal Therapy
Yes 39682 34% 371193 38% 410875
No 77428 66% 602594 62% 680022
Missing 28918 20% 225736 19% 254654
Previous biopsy
Yes 12717 15% 98556 15% 111273
No 70323 85% 567300 85% 637623
Missing 62988 43% 533667 44% 596655
Removed benign lesion
Yes 9255 11% 71088 11% 80343
No 73910 89% 597205 89% 671115
Missing 62863 43% 531230 44% 594093
Age at menarche
< 10 374 0% 2193 0% 2567
10-13 45025 53% 361472 53% 406497
14-16 37869 45% 307932 45% 345801
>16 1459 2% 8478 1% 9937
Missing 61301 42% 519448 43% 580749
Age at menopause
< 40 5100 5% 34727 4% 39827
40-49 44395 42% 354091 40% 398486
50-59 55725 53% 499734 56% 555459
> 59 687 1% 4712 1% 5399
Missing 40121 27% 306259 26% 346380
Number of children
0 9436 11% 64195 9% 73631
1 11412 13% 77080 11% 88492
2 32828 38% 287140 42% 319968
3 20959 24% 182561 26% 203520
>3 11261 13% 78644 11% 89905
Missing 60132 41% 509903 43% 570035
Age at first birth
< 20 15667 21% 105729 17% 121396
20-29 52143 69% 456030 74% 508173
30-39 7523 10% 56237 9% 63760
40-49 330 0% 2348 0% 2678
> 49 13 0% 63 0% 76
Missing 70352 48% 579116 48% 649468
Use of contraceptives
Yes 42364 50% 327222 50% 369586
No 42935 50% 354666 50% 397601
Missing 60729 42% 517635 43% 578364
Family history of breast cancer
Yes 7925 5% 61780 5% 69705
No/Missing 138103 95% 1137743 95% 1275846
Total 146028 100% 1199523 100% 1345551
Chapter 7
Discussion
In this thesis we have used causal inference to create a framework in which it is
possible to estimate the true screening effect on breast cancer mortality. We have
described under which assumptions an observational study can be used and em-
phasized the challenges of this method when applied to screening data. The es-
timated result given in this thesis are likely to be influenced by the limitation of
unmeasured confounders. Thoughts on that issue have been presented, and the
magnitude of the lack of exchangeability between the comparison groups has been
discussed.
Causal inference can be used as a tool for comparing the effect of an inter-
vention in a population. In a randomized study, association is causation because
of (conditional) exchangeability between the groups. For observational studies,
this exchangeability must be arranged by standardization or inverse probability
weighting. We have used the theory of causality to estimate the effect of mam-
mographic screening on breast cancer mortality. Our estimate rely on the assump-
tion of no unmeasured confounders and no model misspecification. We included
three sets of weights correcting for selection bias due to selection of screening strat-
egy, and censoring due to loss of follow up and artificial censoring. The weights
were combined and used to create two sets of pseudo-populations, one using non-
stabilized weights and one using stabilized weights. We fitted three separate Cox
proportional hazard models, one with each weighting procedure. The women fol-
lowing the screening strategy never attend screening had a 62%, 59% and 63% higher
risk of breast cancer mortality compared to the women following the screening
strategy attend at all invitations, in the original, the non-stabilized weighted and the
stabilized weighted population, respectively.
The estimated hazard ratios of breast cancer mortality presented in this thesis
are associated with uncertainty due to unmeasured confounders. It is reasonable to
believe that the women choosing to attend screening are different when it comes to
general health conditions and breast cancer death, compared to the women choos-
ing to not attend screening. Possible risk factors for breast cancer death include
prognostic factors of breast cancer, socio-economic status, general health condi-
tions, lifestyle factors, health awareness and use of hormonal therapy. The lack of
exchangeability can represent a number of unmeasurable factors and measurable
factors that are unavailable in the current data material. For simplicity, we think of
all these factors as one factor combined, and we refer to it as the healthy screening
effect. We think of this selection bias as an underlying factor that is present for
the screened women and which represents healthy lifestyle, social responsibility
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and good physical condition. A sensitivity analysis was conducted to look at how
strong this healthy screening effect must be in order to eliminate the effect of at-
tendance to screening. Such a measure can explain the instability of the estimated
hazard ratios and the uncertainty related to unmeasured confounders. By fitting a
Cox proportional hazard model with an offset to the pseudo-population created,
we found that any healthy screening effect must be at least 7 times stronger in the
screened women, compared to the non-screened women. This result supports the
assumption of a strong healthy screening effect and should be investigated fur-
ther in future research. The analysis can possibly be improved by presenting a
more complex choice of u(a, v, l). The magnitude of the healthy screening effect is
likely to differ between counties and over time, and thus a more refined choice of
the parameter can give a more accurate assessment of the lack of exchangeability.
The availability of private clinics where mammographic screening is offered can
have an effect on the magnitude of selection bias. If a large number of women
choose to attend screening in private clinics and reject invitations to the NBCSP,
the amount of women not attending due to poor general health is lower, and the
healthy screening effect is reduced. Another issue related to opportunistic screen-
ing is the contamination of the defined screening strategies. When we are unable
to observe which women attend screening in private clinics, we can not know if the
women registered as non-screened in our data material actually do opportunistic
screening outside the NBCSP.
When estimating the effect of mammographic screening on breast cancer mor-
tality, a clear definition of the comparison groups is needed. We compare women
regularly screened with women never screened. A large part of the women con-
tinue their screening strategy, and thus we censor a small part of the study popu-
lation with this definition. The methods described for estimating the causal effect
of screening can be applied with any other definitions of the screened and the
non-screened women, although the results may differ with alternative definitions.
In fact, it would be of great interest to study a larger set of screening strategies,
where we could distinguish between the women regularly screened, women never
screened, and those attending irregularly. The latter group are the ones we censor
in this thesis, and consist of women having more than 2.5 years intervals between
two attendances to screening. We expect that this group of women have a lower
effect of mammographic screening compared to those always attending, because
these women have longer time intervals between the attendances to screening. For
the same reason, we expect the irregular attendees to have a lower breast cancer
mortality than the women never attending screening. An ideal time interval is
likely to differ between individuals based on predictive factors such as age, HT,
family history of breast cancer and breast density. By defining the valid screen-
ing strategies differently, we can compare breast cancer mortality between women
with different underlying risks of breast cancer death, and study if there is an ideal
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time interval for these women in which the effect of mammographic screening is
similar to a reference population.
This thesis contains a detailed description of why causal inference can be a use-
ful tool when estimating the effect of mammographic screening. We show that
observational studies can be used to find the true effect by using methods of stan-
dardization or IPW. We can compare any attendance pattern by specifying multi-
ple valid screening strategies. The limitation of the method is the assumption of no
unmeasured confounders, and with the data available in this thesis, we are unable
to estimate the true effect of mammographic screening. The factors included in the
IPW gives small changes to the estimated hazard ratio, indicating that there is little
bias we can correct for using the available variables. Perhaps we will never be able
to meet the underlying assumptions when using register based data, and we will
have to use other sources of information to be able to correct for the healthy screen-
ing effect. As the Cancer Registry store tumor characteristics of all cancer cases and
administrative variables from the screening program, we will most likely not find
new covariates that can explain parts of the healthy screening effect. Self-reported
data from surveys and questionnaires cover topics that are more likely to explain
the underlying difference between screened and non-screened women. For use of
hormonal therapy, we indicated that women screened use on average more HT
compared to women never screened. This information would be very interesting
to study on an individual level for all women invited. This could be solved by
sending a copy of the NBCSP questionnaire to the women not attending, such that
the same information is available on non-attendees as for the attendees.
For future work, it will be necessary to combine data from a large number of
sources, such that we have information on as many risk factors for breast cancer
death as possible. There are several registries in Norway storing data on differ-
ent parameters related to social and demographic factors. All such sources keep
data on an individual level and can be linked together using the personal 11 digit
number. An application is sent to Statistics Norway, combining individual data
from several registries to the data available at the Cancer Registry. Thus, we will
receive information on socio-economic status and lifestyle factors, use of hormonal
therapy, number of children, birth country as well as attendance and breast cancer
death. With all these covariates available, we can apply the framework described
in this thesis, and study differences between the women following the screening
strategies. For future research applying causal inference to screening data, this will
be a useful tool for estimating the effect of mammographic screening on breast can-
cer mortality.
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A ADDITIONAL RESULTS
Appendix A
Additional results
A.1 Attendance patterns of 4 invitations
In this section we will describe an alternative study population where we include
only women who can expect to receive at least four invitations to the screening pro-
gram within the study period. Compared to the original inclusion criteria where
every woman in the study population could expect to receive at least three invi-
tations, this includes in total a lower number of women, and on average a higher
number of invitations per woman. By increasing the maximum number of invi-
tations to each woman in the dataset to 4, we must include eight more combina-
tions of attendances and non-attendances into the term history of attendance (OOO,
OOX, OXO, etc.). With 15 possible combinations, we get a valuable possibility to
compare the probability of attendance among the irregular attendees. Among the
392 760 women in this study population, 87% actually received at least 4 invita-
tions in total throughout the study period (Figure 10). Approximately 9% of the
screened women do not attend at the next invitation, whereas approximately 29%
of the non-screened women attend at the next invitation.
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Figure 10: Float chart of the women who can expect to receive at least four invitations to the screening program within the study period
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Similarly as in chapter 3, we fit a set of logistic regression models, one for each
invitation number. Adjusting for age at invitation (V) in addition to year of invita-
tion and county of residence (L), the results are shown in Figure 11. The probability
of attendance is stable over age and year of invitation
Similarly as for the results in chapter 3, we observe a higher probability of at-
tending the screening for those who previously attended. Among those who at-
tended once in two invitations, the women attending at the second invitation (OX)
have a higher probability of attending compared to those attending at the first in-
vitation (XO). Looking at the probability estimates for the attendance at the fourth
invitation, there is large differences between the irregular attendees. Among these,
the women with attendance history OXX has the highest estimate of probability of
attending, whereas the women with attendance history XOO are related to the
lowest estimated probabilities. This indicate that the attendance status at the pre-
vious invitation is a strong predictor for attendance at the current invitation, and
the total number of attendances are less important.
A.2 Probability of being censored
In Section 5.7 we described how to estimate the effect of attendance on breast can-
cer mortality by using inverse probability weighting. The attendance is catego-
rized into screening strategies, and in order to make these groups comparable we
need to implement the method of IPW. The censoring due to loss of follow-up and
the artificial censoring may introduce bias when comparing these groups, and we
therefore fit a logistic regression model for each type of censoring and compute
individual probability weights. We fit one model for each invitation where the
women are at risk for being censored, and we fit separate models for women regu-
larly attending and women never attending. The models are adjusted for a spline
function of age and year of invitation and a categorical variable of county of resi-
dence. Figure 12 shows the estimated probabilities for being censored due to loss
of follow-up and artificial censoring. The two left sub-figures show the estimated
probabilities for being censored for women based on information at their first in-
vitation. The probability of being artificially censored in the second time interval
is calculated based on the information from the first invitation. Similarly, the two
right sub-figures show the probability of being censored due to loss of follow-up
in the second time interval, and the probability of being artificially censored at the
next invitation. The top sub-figures show these probabilities over age at invitation,
and the bottom sub-figures show the probabilities over year of invitation.
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Figure 11: Estimated probability of attending the screening program at invitation number 1, 2, 3
and 4, by age and year of invitation.
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Figure 12: Probability of being censored due to loss of follow-up and artificially censored by year
of invitation.
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Appendix B
Programming in Stata
Data management and all analyses are done in Stata statistical software (Stata-
Corp, 2013). Data and analyses presented in chapter 2-5 are based on one data
set including all essential information. Basic operations like creation and recoding
of variables are used throughout the programming code (generate, replace, tostring,
destring, recode). We need to reshape the data set from long to wide formats (re-
shape), define survival-time data (stset) and split all observations into time intervals
(stsplit). Logistic regression models are fitted for each time interval (logit) using
spline functions (bspline). Further, the individual probabilities are predicted using
predict and plotted by using twoway mspline.
Calculations and plots of inverse probability weights are done (bysort, bspline,
logit, predict, twoway mspline). Creation of the pseudo-populations and Cox pro-
portional hazards models are programmed using stset with options of weighting
(pweight) and then stcox. Nelson-Aalen estimates are calculated using sts graph.
For the analyses presented in chapter 6, we have used additional data sets orig-
inated from the questionnaire data and data on overall mortality (merge, import). In
sensitivity analysis we used stcox including the option of an offset (offset). Differ-
ent values of α was implemented using vectors (mata, st_matrix). We ran through
the different values of α by programming loops (forvalues) and stored the corre-
sponding results of the weighted Cox proportional hazard models from each iter-
ation in a matrix. The overall mortality was studied by fitting a Cox proportional
hazards model changing the main outcome to all cause death (stcox). The informa-
tion from the two questionnaire forms are combined to one using several different
operations (egen, cut, collapse,merge), and the figures and tables are produced using
twoway line, tabstat and table.
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